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Abstract  
This thesis covers a variety of topics and analyses related to early nutrition on the 
impact it has on the development of lung immunity in the piglet.  In the first section, an 
introduction is given.  In short, neonates are susceptible to infection early in life, 
especially respiratory infections (Murphy et al. 2008).  Respiratory infections are a major 
cause of morbidity and mortality in infants and children world-wide.  The immune 
system exists to protect the host against infection and to help the neonate respond 
appropriately to critical transition periods of life, namely birth and weaning where the 
infant is exposed to a variety of new environmental and food antigens.  Deficiencies of 
the immune system, both innate and adaptive immunity contribute to impaired host 
defense (Marodi and Notarangelo 2007) which can lead to increased susceptibility to 
infection.  Exposure to dietary antigens influences the rate of maturation of the immune 
system (Kelly and Coutts 2000) and can even help provide a protective effect against 
infection.  Breast milk is the optimal form of nutrition and is thought to help the immune 
system develop by providing signals to the immune system (Kelly and Coutts 2000), 
contributing bioactive components and stimulating the release of cytokines in peripheral 
blood mononuclear cells (PBMC) (Bessler et al. 1996) thus decreasing the risk of 
pneumonia (Chantry et al. 2006), upper respiratory, lower respiratory and gastrointestinal 
infections (Duijts et al. 2010).  Despite the benefits of breast milk, only about 13% of 
infants are exclusively breastfed by 6 months of age (CDC 2010), therefore, increased 
understanding of lung immune characteristics and how they differ between breastfed and 
formula infants is necessitated. 
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The next section of the thesis looks at developmental differences in lung, 
mediastinal lymph nodes, and thoracic lymph nodes in breastfed compared to formula-fed 
piglets.  In this study, colostrum-fed newborn piglets were either fed medicated sow milk 
replacer formula beginning at 48 hours of life (n=11) or remained with the sow (n=12) 
throughout the duration of the study.  On d7 and d21 postpartum, approximately half of 
the piglets in each group were euthanized and blood and tissue samples were collected.  
Immune cells in the lungs, MSLN and TLN were analyzed through a variety of 
techniques.  T lymphocyte subpopulations were identified using flow cytometry, cytokine 
mRNA expression was evaluated via RT-PCR, and total IgG, IgM, and IgA 
concentrations in serum were analyzed using enzyme linked immunoabsorbant assay 
(ELISA).  Both dietary (SR vs. FF) and developmental effects on immunological 
development were observed.  Through flow cytometry, it was found that NK cells were 
affected by diet in TLN, but not in PBMC or MSLN.  However, an effect of day (e.g. 
development) was seen in PBMC NK cells.  CD4+CD8+ T cell ratios were not different 
between FF and SR piglets in PBMC; however, diet affected MSLN at d21 and TLN at 
d7.  Expression of CD4+CD8+ double positive T cells in PBMC were affected by day, 
while diet effects were seen in TLN on d7 and MSLN on d21.  mRNA expression was 
investigated in whole tissue samples from the lung, TLN, and MSLN.  Diet also affected 
the mRNA expression of IL-1β and TNF-α in TLN, dectin, IFN-α, and TGF-β2, in 
MSLN and IFN-β in lung tissue in which FF animals had higher mRNA expression than 
the SR counterpart.  In addition, the expression of TLN IL-12 and dectin and MSLN IFN-
α decreased over time while lung IL-6, TGF-β1, INF-α, and TNF-α increased over time.  
Turning to systemic immunity, serum IgG concentrations were lower in the SR piglets 
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than FF piglets (p<0.05), and IgG levels in d7 animals were higher than at d14 and d21 
(p<0.05).  Serum IgM concentrations were not significantly different in SR piglets 
compared to FF piglets nor did the concentrations exhibit developmental changes.  Serum 
IgA levels were lower in the SR piglets when compared to the FF piglets (p<0.05), and 
IgA levels in d7 animals were higher than on d14 and d21 (P<0.05).  The findings of this 
study have established a set of baseline measurements that establish the developmental 
changes in immune cells populations and cytokine expression in bronchial associated 
lymph tissues.  Furthermore, these data demonstrated that differences exist between SR 
and FF piglets and provide a framework for future respiratory challenge studies to 
continue to pinpoint diet/immunological factors that increase the neonate‟s ability to 
resist respiratory infections and recover more quickly from pathogenic invasion.   
 This developmental study also established a foundation of normative changes 
over time for future studies to probe effectiveness of various formula components on 
mucosal lung immune development.  The next section of the thesis discusses one 
component, β-glucan, and the effect it has on mucosal lung immune development.  In this 
study, piglets (n=5-6/group) were fed formula containing 0 (control), 5 (WGP5), 50 
(WGP50), or 250 (WGP250) mg/L formula.  Half of the piglets in each treatment were 
vaccinated (FV) by i.m. injection against influenza (Fluzone™, Sanofi Pasteur, 
Swiftwater, PA) on d7 and received a booster on d14. Piglets were euthanized on d7 and 
d21. Weight gain and formula intake were unaffected by diet or vaccination. Fluzone-
specific serum IgG concentrations was measured by ELISA.  FV piglets had higher 
(p<0.0001) fluzone-specific IgG titer at d14 and 21 than non-V piglets independent of 
diet. Vaccination response were unaffected by oral WGP supplementation.  TNF-α, 
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dectin, IL-1α, -2, -4, and -12 mRNA expression in lung were unaffected by age or dietary 
WGP.  Lung TGFβ-1 mRNA expression was greater (p<0.05) at d21 than d7, and lung 
TGFβ-2 mRNA was lower (p<0.01) in all WGP diets compared to control. TNF-α, 
dectin, TGFβ-1, IL-2, -4, -6, or -12 mRNA in mediastinal lymph nodes (MSLN) were 
unaffected by age or dietary WGP. In MSLN, TGFβ-2 mRNA expression increased from 
d7 to d21 (p<0.05).  TNF-α, TGFβ-1, TGFβ-2, IL-4, -6, or -12 mRNA in thorasic lymph 
nodes (TLN) were unaffected by age or dietary WGP.  Dectin mRNA expression in TLN 
was lower at d21 compared to d7 (p<0.05). T-cell phenotypes were examined in MSLN 
and TLN by flow cytometry.  In MSLN and TLN, CD4+ T-cells decreased, while CD8+ 
T-cells increased between d7 and d21 piglets (p<0.001), but these developmental patterns 
were unaffected by dietary WGP.  Total serum IgG, IgM and IgA concentrations were 
also analyzed via ELISA.  Total serum IgG, IgM and IgA were unaffected by WGP but 
followed typical developmental patterns.  Thus, with the exception of reducing TGFβ-2 
mRNA in lung, dietary WGP did not affect cytokine expression, T-cell phenotypes or 
vaccination response in piglets.  The thesis comes to a close with a discussion of overall 
conclusions and future directions for this work.  
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Chapter 1 
Literature Review 
Neonatal Immune Development  
The immune system exists to protect the host against pathogenic organisms.  This 
defense is particularly critical during periods of transition when neonates are subjected to 
major stressful events such as birth and weaning.  Neonates are susceptible to infections 
early in life, especially respiratory infections.  Deficiencies of both innate and adaptive 
immunity contribute to impaired host defense (Marodi and Notarangelo 2007). Highly 
complex pathways of recognition, response, elimination and memory have evolved in 
order to help protect the host especially at these vulnerable times in life. In addition to 
protecting the infant from infection, the immune system acts to ensure tolerance to „self‟, 
to food, and to other environmental components.  Development and maintenance of 
tolerance begins at an early age, sometimes even prenatally (Calder et al. 2006). A 
breakdown of tolerance can lead to inflammatory diseases 
Neonates are born with an impaired production of TH1-T-cell associated cytokines 
due to a maternal TH2 bias during pregnancy, which is necessary to prevent the mother 
from generating an immune response against the developing fetus.  This TH2 bias creates 
a TH2 dominance in the fetus.  However, this bias against TH1 cytokines leaves the 
newborn susceptible to microbial infection and, if the neonate is not able to effectively 
down-regulate the pre-existing TH2 dominance and overcome low levels of allergen-
specific IgE antibodies, an allergic phenotype may develop (Calder et al. 2006). Classic 
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TH1 cytokines are interleukin (IL)-2, IL-12, and IFN-γ whereas the classic TH2cytokines 
are IL-4 and IL-10. 
Exposure to bacteria during delivery and on the mother‟s skin, as well as the 
introduction to formula and eventually solid foods, are key events in stimulating the 
maturation of the infant‟s gastrointestinal and immune systems.  Early nutrition exposes 
the infant to novel food antigens and may be the source to which the immune system 
must become tolerant.  These factors influence the development of the intestinal 
microbiota, which, in turn, affects antigen exposure, immune maturation, and immune 
responses (Calder et al. 2006).   
  
Neonatal Piglet Immune System  
The piglet is a good model to study neonatal immune development for several 
reasons.  Unlike some other mammals, the pig can be reared independently of their 
mothers and can survive on bovine milk-based sow-milk replacer formula.  They are 
sufficiently large in body size at birth, which allows for extensive surgical manipulation 
and long-term dietary treatment protocols (Calder et al. 2006).  Piglets have similar 
respiratory and digestive system physiology and development as human infants.  
Furthermore, due to the piglet‟s rapid growth rate compared to the infant, the effects of 
experimental dietary treatments can be observed more rapidly.   
Piglets are susceptible to similar diseases and pathogens as humans.  For example, 
clinical signs of influenza in pigs are comparable to those in humans (Haesebrouck and 
Pensaert 1986).  Pigs are a particularly good model because they are susceptible to 
human and avian influenza viruses (Ito et al. 1998).  
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Piglets secrete defense proteins, peptides, cytokines, and chemokines that are 
homologous to those of other mammals (Butler et al. 2009).  The lymphoid cell 
populations, cells that mediate the production of immunity, of the pig are shown to be 
consistent to other vertebrates, especially humans (Boeker et al. 1999), with the 
exception of expressing greater proportions of CD4+/CD8+ double positive (DP) 
lymphocytes, comprising between 8 to 64% of the circulating pool of small resting T-
lymphocytes (Pescovitz et al. 1985; Pescovitz et al. 1994; Zuckermann and Husmann 
1996; Zuckermann and Husmann 1996) compared to <3% (Zuckermann 1999) in the 
human counterpart, in peripheral blood and secondary lymphoid organs.  
One primary difference between the piglet and the human infant involves the 
transfer of passive immunity.  The pig is born with virtually no serum immunoglobulins 
(Ig) due to the lack of placenta transfer (Gaskins and Kelley 1995) and, therefore, are 
dependent upon ingestion of colostrum and milk to obtain Ig (Bourne 1976). In contrast,  
human infants receive passive immunity both in utero via placental transfer of Ig and 
postnatally via consumption of colostrum and milk postpartum (Bourne 1976; Sangild 
2006).   
Maternal immunity, including specific systemic humoral immunity, involving 
mostly IgG, is transferred from the maternal circulation into colostrum and is typically 
absorbed within the neonatal intestine by macromolecular absorption.  In addition, 
secretory IgA (sIgA), produced by the mammary gland, provides local immune 
protection within the piglet intestine. These antibodies are produced by the sow in 
response to intestinal and respiratory antigens and are passed on to the piglet to help 
protect the piglet against local pathogens (Salmon et al. 2009).  Immunoglobulins play a 
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key role in host defense by forming IgA and antigen complexes in the lumen of the 
intestine.  The content of IgA antibodies from milk gradually declines throughout 
lactation, allowing bacterial colonization to occur (Salmon et al. 2009).  In addition to 
IgG, transfer of cytokines from colostrum to the bloodstream of the piglet peaks at two 
days after birth, which coincides with gut permeability; typically, gut closure occurs 24-
36 h after birth (Nguyen et al. 2007).  
 
Lung Mucosal Immunology 
The first point of contact for inhaled substances such as environmental pollutants, 
cigarette smoke, airborne allergens and microorganisms are the epithelial lining of the 
upper airways and lungs (Diamond et al. 2000).  The lungs and upper airways are 
mucosal surfaces that have dual function; they protect the organism from invasion of 
foreign antigens and bacteria, while allowing for the exchange of materials with the 
environment.  Due to the high exposure of the lungs and upper airways to airborne 
pathogens, they are common sites for infection.  Mucosal defense mechanisms are, 
therefore, critical for preventing colonization of the respiratory tract by pathogens and 
penetration of antigens through the epithelial barrier.   
The mucosal surfaces provide both nonimmune and immune mucosal defense.  
Tight junctions connect the epithelial cell layer covering most of the mucosal surfaces 
creating a physical barrier for pathogens and antigens.  A mucus layer forms that retards 
the movement of microorganisms and allows for the sequestering of pathogens and 
antigens.  If bacteria stick to the mucus layer before they can reach the target cell 
5 
 
receptor, they are swept away from the organism by other nonspecific defense 
mechanisms such as coughing, sneezing and mucociliary clearance.    
The goal of the mucosal innate immune system is to discriminate between 
pathogen-associated and „harmless‟ antigens, expressing active responses against 
pathogens and tolerance to harmless antigens (Bailey et al. 2005). Components of the 
innate immune system include phagocytes, such as neutrophils and macrophages (mø), 
natural killer (NK) cells, basophils, mast cells and eosinophils (Bals and Hiemstra 2004).  
The mucosal immune system is organized such that lymphoid elements of different 
mucosal tissues are collectively known as mucosal-associated lymphoid tissue (MALT), 
which then is separated into several components.  These components included gut-
associated lymphoid tissue (GALT), the bronchus-associated lymphoid tissue (BALT), 
the nasopharynx-associated lymphoid tissues (NALT), the mammary glands, and the 
genitourinary lymphoid tissue (Mestecky and McGhee 1987). BALT is made up of 
peribronchial, mediastinal, and cervical lymph nodes, mucosal epithelia, and lymphoid 
follicles sites, where foreign antigens are encountered and selectively taken up for 
initiation of immune responses (Vancikova 2002).  
In recent years, it has become clear that airway epithelial cells not only provide a 
passive barrier function, but also actively contribute to the innate immune system 
(Diamond et al. 2000; Holgate et al. 2000).  The airway epithelium senses bacterial 
exposure and responds by increasing its defenses. This response consists of an increase in 
the release of antimicrobial peptides into the lumen of the airways, and the release of 
chemokines and cytokines into the submucosa that initiate an inflammatory reaction. This 
inflammatory reaction includes the recruitment of phagocytes that serve to remove 
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microorganisms, and dendritic cells and lymphocytes that may aid in mounting an 
adaptive immune response (Bals and Hiemstra 2004).   
There are several proposed mechanisms by which pathogens are recognized by 
the airway epithelium that lead to a protective response of the innate immune system.  
Cells of the innate immune system use pattern recognition molecules to bind to conserved 
molecular patterns that are present on microorganisms.  Toll-like receptors (TLR) are one 
such family of pattern recognition receptors.  The TLRs help shape the adaptive immune 
response by directing the way that DC „educate‟ T-cells.  Activation of TLRs also 
regulates the expression of a variety of genes, including cytokines and chemokines. 
Airway epithelial cells secrete molecules that are involved in inflammatory and immune 
processes (Diamond et al. 2000; Holgate et al. 2000).  These include cytokines, 
chemokines, leukotrienes, calprotectin, β-defensins and other factors (Bals and Hiemstra 
2004).  By secreting these molecules, the airway epithelium is capable to chemoattract 
and activate cells of the innate and adaptive immune system, to immobilize and kill 
microorganisms, to induce wound healing and angiogenesis in response to injury and to 
orchestrate the initiation of and adaptive immune response (Bals and Hiemstra 2004).   
 
Porcine Response to Vaccination 
  While the immune system of the piglet is anatomically developed at birth, it is 
functionally immature and several weeks are necessary for full functional maturation for 
many components of the immune system (Gaskins 1998).  It is important that active 
immunity develops rapidly and appropriately in the piglet as immune protection acquired 
from colostrum does not confer protection against antigens to which the sow had not been 
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exposed.  The rate of maturation of the immune system is influenced by exposure to the 
intestinal microflora and to dietary antigens (Kelly and Coutts 2000).  The components of 
the immune system are present before birth as the piglet has the ability to synthesize IgG 
in response to an antigen challenge in utero and spontaneously IgG-secreting thymic B-
cells are detectable in 67-day-old pig fetuses (Gaskins 1998; Rooke and Bland 2002).  
The age at which the suckling piglet accumulates appreciable concentrations of IgG by de 
novo synthesis appears to be at ~7 days of age in both naturally-suckled (Rooke et al. 
2003) and artificially-reared piglets (Drew and Owen 1988).  
Vaccines can play an integral role in protecting the young pig against various 
diseases. It requires 10 to 21 days after vaccination for the pig to mount a protective 
immune response.  The exact length of time depends on the pig‟s age, the vaccine 
administered, and whether the pig had been vaccinated with the same vaccination before 
(Haesebrouck et al. 2004).  Vaccination against swine influenza virus can greatly reduce 
or prevent virus replication after challenge and the resulting disease (Van Reeth et al. 
2002).  Reeth and colleagues (2002) showed that piglets vaccinated against swine 
influenza virus (SIV) and then challenged had lower virus titers than the non-vaccinated 
pigs, reduced production of cytokines in the lungs upon challenge, and had clear 
reductions in disease severity.  
 
Influenza Vaccination 
 Influenza is primarily a respiratory tract infection involving the inflammation of 
the respiratory tract, which can progress to life-threatening pneumonia, 
hypercytokinemia, edema, acute lung injury, respiratory failure and death.  Influenza is 
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contagious and occurs worldwide.  About 20% of children and 5% of adults develop 
influenza A or B every year (Nicholson et al. 2003), which kills about 36,000 Americans 
every year (Fiore et al. 2008).  Young children are more likely to catch influenza than 
older children or adults (Nicholson et al. 2003).  Symptoms of influenza include croup, 
bronchiolitis, asthma, bronchitis, and otitis media.  
There are three types of influenza viruses: A, B and C.  Human influenza A and B 
viruses cause seasonal epidemics of disease while influenza type C infections cause a 
mild respiratory illness and are not generally associated with seasonal epidemics [CDC 
http://www.cdc.gov/flu/about/viruses/types.htm accessed Feb. 2, 2011].  Influenza type A 
viruses can be divided into two subtypes based on two proteins on the surface of the 
virus: the hemagglutinin (HA) and the neuraminidase (N).  There are two different 
subtypes of influenza A recognized in people at this time.  They are influenza A (H1N1) 
and influenza A (H3N2) viruses.   
Vaccination remains the most effective first line of defense for people of all age 
groups against seasonal influenza (Wong et al. 2010). The risk of infection and 
associated morbidity and mortality is significantly reduced by vaccination against the 
pathogen Haemophilus influenza (H. influenza) (Fiore 2010).  The benefits of annual 
immunization via intramuscular injection of high-risk populations with injectable 
trivalent inactivated influenza vaccines have been well established over the years.  
Fluzone® vaccines (Sanofi Pasteur, Swiftwater, PA) are given for active 
immunization against influenza disease caused by influenza viruses: influenza A (H1N1), 
influenza A (H3N2), and type B (Fiore 2010).  Fluzone® is an inactivated vaccine, also 
known as the flu shot, which is given by injection into the muscle.  Influenza vaccines 
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have been known to produce a protective effect, which is largely dependent on the 
vaccine's ability to stimulate circulating antibody to the HA (Hobson et al. 1972). 
Vaccination against H. influenza is currently recommended for all children 6 months and 
older. In addition, a recent randomized double blind placebo controlled study conducted 
in 1375 healthy U.S. infants demonstrated that Fluzone® administered to young infants 
beginning at 6 to 12 weeks of age was safe and immunogenic (Englund et al. 2010).  
Another option for vaccination delivery is through a nasal spray FluMist® (MedImmune 
Vaccines, Inc. Gaithersburg, MD).  The FluMist® offers an effective line of defense 
against seasonal influenza without having needle shots.  In contrast to the injectable 
vaccine, FluMist® is a live trivalent vaccine which has been shown to induce protective 
immunity in the respiratory tract (McCarthy and Kockler 2004).   
 
Nutritional Regulation of Immune Function 
 Evidence suggests that the composition of the diet influences the functioning of 
our immune system (Volman et al. 2008).  Innate immune defenses are critical, especially 
immediately following birth and during the weaning period when the neonate is subject 
to a vast array of potentially pathogenic microorganisms that were not encountered in 
utero or during the first few months of life, respectively.  The intestine is the largest 
immune organ in the body and, therefore, is a location that is exposed to vast quantities of 
dietary and microbial antigens (Kelly and Coutts 2000).  The development of the normal 
immune function of the intestine is, therefore, vital for survival and is dependent on 
appropriate dietary and pathogenic antigen exposure among other things (Kelly and 
Coutts 2000).   
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It is generally accepted that the generation of appropriate immune responses and 
the development of immune regulatory networks in the neonate are dependent on the 
development of a normal intestinal flora as well as exposure to dietary antigen 
(Brandtzaeg 1996).  Furthermore, immunological response following antigen exposure is 
determined by a number of factors including genetic background, nature, timing, and 
dose of the administered antigen (Strobel and Mowat 1998).  As previously mentioned, 
the innate immune system plays an important role in the elimination of infectious agents 
while minimizing the damage they cause and, at the same time, they play an equally 
important role in processing harmless antigens.  Failure to regulate the processing of 
harmless antigens correctly can lead to disease such as food-related allergy, 
autoimmunity, and inflammatory bowel disorders (Kelly and Coutts 2000).  Due to the 
impact that antigens have on development of the immune system, it is critical that 
neonates are exposed to appropriate antigens through nutrition suited for immune 
development. 
It is generally accepted that infants who are breast-fed have fewer infections 
compared with those who are formula fed. There is consistent evidence, in both 
developed and developing countries, that breast-feeding provides a protective effect in 
the first 4-6 months of life (Golding et al. 1997).  In addition to supplying  nutrition, 
maternal colostrum and milk also protect the neonate against gastrointestinal and 
respiratory diseases (Kelly and Coutts 2000) and have been shown to promote the 
maturation of the developing intestinal epithelium (Burrin et al. 1992; Wang and Xu 
1996).  
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There is also a considerable body of literature describing immunosuppressive 
effects of breast-feeding and maternal antibodies on the development of active immune 
responses (Rennels 1996; Hodgins et al. 1999).  During the early stages of life, maternal 
milk provides signals to the immune system that help develop appropriate response to 
antigens (Kelly and Coutts 2000).  Breast milk also contains several bioactive 
components including human milk oligosaccharides (HMO), cytokines such as 
interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-18, IFN-γ, TNF-α, and 
TGF-β, as well as, immune cells.  Breast-fed infants also have increased NK cells counts 
and higher antibody titres than formula-fed infants (Grimble and Westwood 2001).  The 
majority of lymphocytes in milk are activated T-cells that express the surface antigen 
CD45RO+ and are often associated with immunological memory (Goldman and 
Goldblum 1997).  There is evidence to suggest that the lymphocytes from milk can attach 
and traverse the neonatal intestine, and can remain locally with the intestine or migrate to 
enter circulation (Goldman and Goldblum 1997; Xanthou 1997).   
 
Bioactive Components in Human Milk 
Human colostrum has been shown to stimulate the release of cytokines from 
peripheral blood mononuclear cells (PBMC), thus altering the cytokine background 
against which immunological events are instigated (Bessler et al. 1996).  The CDC report 
card suggests that 75% of infants in the U.S. are breastfed at birth but within the first 6 
months it drops to 43% and only 33% of infants in the U.S. are exclusively breastfed for 
the first 3 months of life (CDC 2010).  Therefore, it is important to supplement formula 
in such a way that neonates can experience similar immunological advantages to those 
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that are breast-fed.  Several bioactive components are being investigated to more closely 
mimic human milk. 
Lactoferrin:  Lactoferrin (Lf), an iron-binding glycoprotein functions to transport 
iron in milk and other secretions (Gonzalez-Chavez et al. 2009).  It is found in most 
biological fluids such as saliva, tears, bile, nasal and bronchial secretions, urine, and most 
highly in milk and colostrum (7 g/L) (Gonzalez-Chavez et al. 2009) and is considered an 
innate defense protein.  It is synthesized by epithelial cells and granuloctyes (Kruzel et al. 
2007) and is released by mucosal epithelia and neutrophils during inflammation (Puddu 
et al. 2009).    
Lactoferrin is involved in several physiological functions, including immune 
response, antioxidant and anti-inflammatory properties, and protection against microbial 
infection (Gonzalez-Chavez et al. 2009). It also aids in controlling the initial reactions to 
infections, trauma, and injury (Kruzel et al. 2007).  It is recognized by low-density 
lipoprotein receptor-related protein-1 and -2 (LRP1 and LRP2) receptors that have been 
identified on macrophages, platelets, and intestinal cells (Kruzel et al. 2007).   
Lactoferrin acts as an antimicrobial agent by limiting the proliferation and 
adhesion of microbes and/or by phagocytosis (Puddu et al. 2009) due to the interaction of 
Lf with anionic molecules on some bacterial, viral, fungal, and parasite surfaces 
(Gonzalez-Chavez et al. 2009).  These properties are mainly related to its ability to 
sequester iron in biological fluids, to destabilize the membranes of microorganisms 
(Puddu et al. 2009), or to bind exogenous pro-inflammatory bacterial components, such 
as lipopolysaccharides and their receptors (Legrand and Mazurier 2010).  Lactoferrin 
seems to exert its antibacterial properties by direct interaction with microbes or by 
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competition with bacteria for iron which then inhibits the growth of the bacteria (Jenssen 
and Hancock 2009; Lonnerdal 2009).  Lactoferrin also exerts anti-viral activity against 
several viruses that infect the gastrointestinal tract including rotaviruses, enteroviruses, 
and adenoviruses (Oguchi et al. 1995; Firth et al. 2005).  Lactoferrin has also been shown 
to stimulate mucosal cell proliferation and differentiation in Caco-2 cells (Oguchi et al. 
1995) which may enhance nutrient uptake. 
Nucleotides:  Nucleotides are low molecular weight intracellular compounds that 
consist of a nitrogenous base (purine and pyrimideine bases), a five-carbon sugar, and 
one to three phosphate groups, and are considered the foundation of RNA and DNA. 
Nucleotides are sources of cellular energy, signal transduction, physiologic mediators, 
coenzyme factors, and regulation of enzyme activity. They are naturally found in all 
foods of animal and vegetable origin as free nucleotides and nucleic acids (Gil 2002) and 
are also commonly found in human breast milk and cow‟s milk.  Bovine milk has 
significantly lower nucleotide content than human milk resulting in infant formula with 
significantly lower nucleotide content than human milk.  Since the goal is to mimic 
human milk as closely as possible, nucleotides have been added to infant formulas.  
Although 13 nucleotides have been described in human milk, only five of them have been 
added to formula (Yu 2002). 
Proteases and nucleases degrade dietary nucleoproteins and nucleic acids into 
nucleotides.  Intestinal alkaline phosphatases and nucleotidases cleave the phosphate 
groups from nucleotides to from nucleosides which are absorbed in the small gut.  The 
absorbed nucleosides are mainly degraded to uric acid and allantoin, but some are 
reconverted to nucleotides (Yu 2002).  Nucleotides also can be synthesized de novo but 
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this process is metabolically costly.  Supplementation of formula with nucleotides may 
prevent the neonate from resorting to the de novo synthesis of nucleotides therefore 
optimizing physiological function.   
Dietary nucleotides have been reported to be beneficial for infants since they 
positively influence lipid metabolism, immunity, and tissue growth, development and 
repair (Gil 2002).  Dietary nucleotides have also been shown to play a significant role in 
the immunological development of neonates.  Research indicates that supplementation of 
infant formula with nucleotides leads to improved growth and reduced susceptibility to 
infection (Grimble and Westwood 2001).  In animal research, nucelotides have been 
shown to increase immune responses and beneficially affect gastrointestinal 
development.    
In particular, it has been demonstrated, in a rat model, that nucleosides contribute 
to enhanced growth and maturation of the gut by increasing villus height and enzyme 
activities (Iwasa et al. 2000).  Another study showed that mice that were fed a diet 
supplemented with 0.5% nucleotide mixture were less susceptible to mortality, had 
increased cell proliferation, greater production of Il-2 and IFN-γ when exposed to 
Cryptosporidium parvum given orally when compared to the counterpart non-nucleotide 
supplemented mice (Adjei et al. 1999).  In another study, weanling mice fed chow plus 
water supplemented with 0.035% nucleotides exhibited increased NK cell activity and 
lower mø activation compared to the mice fed chow plus nonsupplemented water (Carver 
et al. 1990).  Other animal studies have shown that mucosal DNA and protein synthesis, 
disaccharidase activity, villus cell number and height (Uauy et al. 1990) and small 
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intestinal wall thickness and weight are increased (Carver 1994) with nucleotide 
supplementation. 
Human milk oligosaccharides (HMO):  These complex carbohydrates are unique 
because of their structural diversity and high concentrations in human milk.  Human milk 
contains 7-12 g HMO/L, making them the third largest component of human milk 
(Newburg 1997). The oligosaccharide content in the milk of most domestic mammals is 
10- to 100-times lower than that found in human milk (Boehm and Stahl 2003).   
 HMOs are synthesized in the mammary gland starting with lactose at the reducing 
end and are comprised of D-glucose, D-galactose, N-acetylglucosamine, L-fucose, and 
sialic acid (Bode 2009).  The type of oligosaccharides produced in the mammary gland is 
believed to be influenced by maternal genetics, including the mother‟s Lewis blood group 
(Macfarlane et al. 2008).   There are thought to be 12 core structures made up of glucose, 
galactose, and N-acetylglucosamine (Newburg et al. 2005), with over 200 structures 
characterized by mass spectroscopy (Ninonuevo et al. 2006).  HMOs differ not only in 
structure but also in size, charge, sequence, and abundance (Ninonuevo et al. 2006).  
Human milk contains mainly neutral compared to the acidic HMO (Boehm et al. 2005). 
Neutral HMOs contain galactose, N-acetylglucosamine, fucose, and lactose core or 
anionic, whereas acidic HMOs contain the same oligosaccharide composition with N-
acetylneuraminic acid (Ninonuevo et al. 2006). 
Oligosaccharides in human milk are not digestible by small intestinal enzymes 
(German et al. 2008).  The nutritional function that is most associated with HMOs is to 
serve as a prebiotic or indigestible carbohydrate that is fermented by the gut microbiota 
(German et al. 2008).  Microbial degradation and fermentation of HMOs takes place in 
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the colon, providing the resident bacterial flora with the required carbon and energy for 
growth (Crociani et al. 1994).  Evidence suggests that HMOs also act as receptor analogs 
to inhibit the adhesion of pathogens on the epithelial surface and interact directly with 
immune cells (Boehm and Stahl 2007), and protect the breastfed infant against infections 
and diarrhea (Newburg et al. 2005).  HMOs have been demonstrated to selectively 
nourish the growth of highly specific strains of bifidobacteria, thus establishing the 
means to guide the development of the unique gut microbiota in infants fed breast milk 
(Ward et al. 2006).  The presence of bifidobacteria in the infant gastrointestinal tract 
(GIT) has been associated with a number of important health-promoting effects, 
including reduced incidence of diarrheal illnesses, improved lactose digestion, and 
enhanced immunomodulatory functions  (Leahy et al. 2005).   
 
(1,3/1,6)-β-D-Glucan 
Although β-Glucans are not normally found in human milk, they are thought to 
potentially influence neonatal immune development.  The focus of my research was to 
determine the bioactivity of (1,3/1,6)-β-D-Glucan added to formula fed to piglets. 
β-glucans are polysaccharides that occur as a principal component of cellular 
walls.  Yeast, fungi, seaweeds, mushrooms, and some cereals such as oats and barley 
contain large amounts of β-glucans.  β-glucans have been shown to lead to a variety of 
biological responses, including activation of neutrophils (Zhang and Petty 1994), 
macrophages (Adachi et al. 1994; Lebron et al. 2003), complement (Saito et al. 1992) 
and possibly eosinophils (Mahauthaman et al. 1988).  
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β-glucans stimulate the immune system, modulate humoral and cellular immunity, 
and, therefore, help the host to fight infections.  β-(1,3)-glucans belong to the group of 
“Biological Response Modifiers” (BRM), meaning that they do not have direct cytotoxic 
activities, but are able to boost the natural defense mechanisms of the host (Zekovic et al. 
2005; Descroix et al. 2006).  The biological effects of β-glucans are measured through 
activation of natural killer (NK) cells, T-cells, and nuclear factor-kappaB (NF-kB), 
phagocytic activity, stimulation of secretion of cytokines, and production of reactive 
oxygen species (Descroix et al. 2006).  
β-glucans are also antigenic substances that contain pathogen-associated 
molecular patterns (PAMPS), which are identified by pattern-recognition receptors (PRR) 
present on immune cells.  These PRRs include at least four receptors that recognize β-
glucans and allow the innate immune system to mount an immune response against it, 
including dectin-1, complement receptor 3 (CR3; CD11b/CD18), lactosylceramide, and 
scavenger receptors (Descroix et al. 2006).  Several studies support the CR3 receptor as 
the primary receptor mediating the physiological response to yeast (1,3/1,6)- β-D-glucan 
(Baran et al. 2007; Li et al. 2007).   Factors such as solubility, degree of branching, and 
primary structure impact the biological activity of β-glucans.  β-glucans with a degree of 
branching between 0.2 and 0.33, a molecular weight between 100 and 200 kDa, and a 
triple-helix structure are most biologically effective (Zekovic et al. 2005).   
 Further, Beier and Gebert have shown that the uptake of particulate antigenic 
matter, including microorganisms and vaccine-bearing microspheres, by the intestinal 
mucosa is achieved by membranous (M) cells in the domes of Peyer‟s patches (PP) 
(Beier and Gebert 1998).  Following uptake, the particles continue through the dome 
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epithelium into the subepithelial lymphoid tissue where an immune response is often 
initiated (Beier and Gebert 1998).  Using Baker‟s yeast (Saccharomyces cerevisiae) as a 
tracer, Beier and Gebert investigated the kinetics of particle uptake in the PP of pigs 
(Beier and Gebert 1998). Transcytosis of yeast particles by M cells occurred within 1 h.  
Without significant phagocytosis by intraepithelial macrophages, the particles migrated 
across the basal lamina within 2.5-4 h where they were quickly phagocytosed and 
transported out of the PP domes (Beier and Gebert 1998).   
In our study, Wellmune WGP® (Biothera, Eagan, MN) was extracted from cell 
walls of purified Saccharromyces cerevisiae using a proprietary technology, which 
produced a whole glucan particle in which the outer surface of mannoprotein and inner 
cellular contents were removed to expose the β 1,3/1,6 glucan.  WGP is a linear glucose 
molecule with a beta 1,3/1,6 branch point extended by a long β 1,3 oligosaccharide 
[http://immunehealthbasics.com/HowItWorks.cfm, accessed Feb 2, 2011].  WGP yeast 
particles are approximately 2-5 mm in size, which is ideal for uptake into M-cells and PP. 
When WGP is ingested, it is transported to immune organs where it is taken up by PP. 
Macrophages then digest the WGP into smaller fragments that are released over a few 
days [http://immunehealthbasics.com/HowItWorks.cfm, accessed Feb 2, 2011].  Yeast β-
glucan binds to the CR3 receptor (Thornton et al. 1996) and activates or enhances 
neutrophil anti-microbial activity, including migration of immune cells to the site of a 
foreign challenge and increased phagocytosis and oxidative burst. Several animal studies 
have shown beneficial effects of β-glucan. In one such study, mice were given a 
subcutaneous injection of yeast β-glucan (PGG-glucan) and whole glucan particle (WGP) 
β-glucan (Kournikakis et al. 2003).  β-glucan increased survival rate, diminished 
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bacterial load in the lungs, and increased the proportion of bacteria-free animals after 
infection with anthrax in mice (Kournikakis et al. 2003).  In another study, bacterial 
counts in blood of Staphylococcus. aureus (S. aureus)-challenged rats treated 
intramuscularly with PGG-glucan were lower than in control rats, and also the number of 
monocytes and neutrophils were increased (Liang et al. 1998).  Additionally, Rice and 
colleagues (2005) found an increased survival in mice challenged with S. aureus or 
Candida albicans after oral administration of glucan phosphate (GluP). Furthermore, 
Kournikakis et al. (2003) showed that orally administrated WGP β-glucan increased 
survival in mice challenged with the anthrax bacteria. 
In addition, yeast β-glucans have been shown to improve the humoral immunity 
of pigs and modulate cellular immunity of weanling pigs.  Li and coworkers (2005) 
supplemented pigs diets with 50 mg/kg β-glucan.  Pigs were injected with ovalbumin on 
day 14 and lymphocytes were isolated on day 28 and challenged with lipopolysaccharide 
(LPS) ex vivo to assess the impact of β-glucan on cellular immunity of pigs (Li et al. 
2005). They found that β-glucan mitigated the elevation of pro-inflammatory cytokines, 
IL-6, and tumor necrosis factor-alpha (TNF-α), and enhanced the increase of an anti-
inflammatory cytokine (IL-10) after LPS challenge (Li et al. 2005).   
In another study, dietary yeast β-glucans exerted anti-viral effects against SIV in 
piglets that were fed 50 mg/kg β-glucan daily (Jung et al. 2004). On day 3, piglets were 
inoculated intra-nasally with SIV.  Piglets that received the oral β-glucan had 
significantly lower microscopic lung lesion scores and significantly less nucleic acid in 
the lungs than those that did not receive the supplemented feed. Pre-administered β-
glucan also reduced the pulmonary lesion score and viral replication scores in SIV-
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infected piglets (Jung et al. 2004). Yeast β-glucans also had an anti-viral effect against 
porcine reproductive and respiratory virus (PPRS) in weanling pigs (Xiao et al. 2004).  In 
both studies, yeast β-glucan administration was associated with an up-regulation of the 
TH1 cytokine IFN-gamma.  Indeed, a hallmark of WGP therapy is a switch from a TH2 to 
a TH1 response.   
β-D-Glucan has had mixed effects on lung function and airway responsiveness.  
In one study, S. cerevisiae β-glucan fed orally (50 mg/pig) reduced the pulmonary lesion 
score and viral replication rate on pneumonia induced by swine SIV in piglets (Jung et al. 
2004).  In another study, pigs were fed diets with 0.025 or 0.5% β-glucan.  Dietary β -
glucan increased average daily food intake and average daily growth compared to control 
animals; however, pigs fed β-glucan had decreased plasma haptoglobin but more pigs fed 
0.025% β -glucan died by d12 after Streptococcus suis challenge (Dritz et al. 1995).   
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Chapter 2 
Research Objective, Specific Aims, and Hypothesis 
 
Respiratory infections are a major cause of morbidity and mortality in infants and 
children world-wide. Nutrition during infancy impacts the infant‟s immunological 
development and ability to ward off respiratory infections and respond appropriately to 
antigens.  Epidemiological evidence and clinical studies support the concept that 'breast is 
best', due in part to the effects of maternal milk on the immunological development of the 
neonate.  Maternal milk provides signals to the immune system that support development 
of an appropriate antigen response (Kelly and Coutts 2000), as well as contributing 
several bioactive components including HMO, cytokines, and immune cells.  Human 
colostrum has been shown to stimulate the release of cytokines from PBMC, thus altering 
the cytokine background against which immunological events are instigated (Bessler et 
al. 1996). Breastfed infants also have been acknowledged to have increased natural killer 
cells counts, higher antibody titers (Grimble and Westwood 2001), and activated T-cells 
that are often associated with immunological memory (Goldman and Goldblum 1997).  
Despite the clear immunological advantages of breast feeding infants and the 
implications associated with those advantages, not every infant is breastfed, thus, 
establishing a need to identify not only how immune development differs between 
breastfed and formula-fed neonates, but also which bioactive components trigger these 
immunological benefits.  
The overall goal of this thesis research was to investigate how early nutrition 
influences immune development.  The overall hypothesis guiding this research was that 
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immune development differs between breast- and formula-fed neonates and that the 
addition of the BMR β-glucan to formula would mediate immune development of 
formula-fed piglets.  
Specific Aim 1 investigated the development of immune cells in the lungs, 
mediastinal (MSLN) and thoracic lymph nodes (TLN), serum Ig profiles, and tissue 
cytokine mRNA expression in sow-reared (SR) pigs compared to those that were 
formula-fed (FF).  The working hypothesis of this specific aim was that SR piglets would 
exhibit an earlier and more robust immunological development than the FF counterpart, 
which would be manifest through greater percentages of double positive T cell 
populations, greater percentages of NK cells, higher expression of TH1 related cytokines, 
and greater concentrations of total serum IgG, IgA and IgM in SR piglets compared to FF 
piglets.  It is also hypothesized that developmental changes will be observed; double 
positive T cells will likely increase over time, while CD4+ T cells will likely decrease 
over time, CD8+ T cells will likely increase over time, NK cells will likely increase over 
time.  It is also hypothesized that TH1-associated cytokines will likely increase over time, 
while TH2-assoicated cytokines will decrease over time.  It is also likely that total serum 
IgG, IgM and IgA concentrations will decrease from initial d7 concentrations and then at 
some point begin to increase towards d7 concentrations.  Chapter 3 compared serum IgG, 
IgA and IgM concentrations, T-cell subpopulations and NK cells, and cytokine gene 
expression in lung, MSLN and TLN tissue.   
Specific Aim 2 investigated the effect of yeast β-glucan supplemented to infant 
formula on the development of mucosal immunity in the lung as well as the immune 
response to immunization with an influenza vaccine.  The working hypothesis of this aim 
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was that the addition of yeast β-glucan would enhance the immune response by enabling 
a switch from a TH2 to a TH1 response and increase cytokine secretion.  Chapter 4 
compared T-cell subpopulations in TLN and MSLN, gene expression in lung, TLN and 
MSLN tissues, total and Fluzone-specific IgG concentrations in serum, lung 
histomorphology and T-cell immunohistochemistry, and ex vivo proliferation of T-cells 
isolated from the TLN of 7-and 21-day-old piglets fed formula or formula supplements 
with WGP β-glucan.  
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Chapter 3 
Impact of Diet on Development of Lung Immunity in the Neonatal Piglet 
 
Abstract 
Lung immune development is critically important in order to protect neonates 
from foreign pathogens that could lead to respiratory infection. We hypothesized the 
development of immune cells in the lungs of sow-reared piglets differs from that of 
formula-fed piglets.  In this study, colostrum-fed newborn piglets were either fed 
medicated sow milk replacer formula beginning at 48 hours of life (n=11) or remained 
with the sow (n=12) throughout the duration of the study.  On d7 and d21 postpartum, 
approximately half of the piglets in each group were euthanized and blood and tissue 
samples were collected.  Immune cells in the lungs, MSLN and TLN were analyzed 
through a variety of techniques.  T lymphocyte subpopulations were identified using flow 
cytometry, cytokine mRNA expression was evaluated via RT-PCR, and total IgG, IgM, 
and IgA concentrations in serum were analyzed using enzyme linked immunoabsorbant 
assay (ELISA).  Both dietary (SR vs. FF) and developmental effects on immunological 
development were observed.  Through flow cytometry, it was found that NK cells were 
affected by diet in TLN, but not in PBMC or MSLN.  However, an effect of day (e.g. 
development) was seen in PBMC NK cells.  CD4+CD8+ T cell ratios were not different 
between FF and SR piglets in PBMC; however, diet affected MSLN at d21 and TLN at 
d7.  Expression of CD4+CD8+ double positive T cells in PBMC were affected by day, 
while diet effects were seen in TLN on d7 and MSLN on d21.  mRNA expression was 
investigated in whole tissue samples from the lung, TLN, and MSLN.  Diet also affected 
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the mRNA expression of IL-1β and TNF-α in TLN, dectin, IFN-α, and TGF-β2, in 
MSLN and IFN-β in lung tissue in which FF animals had higher mRNA expression than 
the SR counterpart.  In addition, the expression of TLN IL-12 and dectin and MSLN IFN-
α decreased over time while lung IL-6, TGF-β1, INF-α, and TNF-α increased over time.  
Turning to systemic immunity, serum IgG concentrations were lower in the SR piglets 
than FF piglets (p<0.05), and IgG levels in d7 animals were higher than at d14 and d21 
(p<0.05).  Serum IgM concentrations were not significantly different in SR piglets 
compared to FF piglets nor did the concentrations exhibit developmental changes.  Serum 
IgA levels were lower in the SR piglets when compared to the FF piglets (p<0.05), and 
IgA levels in d7 animals were higher than on d14 and d21 (P<0.05).  The findings of this 
study have established a set of baseline measurements that establish the developmental 
changes in immune cells populations and cytokine expression in bronchial associated 
lymph tissues.  Furthermore, these data demonstrated that differences exist between SR 
and FF piglets and provide a framework for future respiratory challenge studies to 
continue to pinpoint diet/immunological factors that increase the neonate‟s ability to 
resist respiratory infections and recover more quickly from pathogenic invasion. 
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Introduction 
Neonates are susceptible to infection early in life, especially respiratory infections 
(Murphy et al. 2008).  In fact, respiratory infections are one of the leading causes of 
morbidity in children (Duijts et al. 2010).  Breastfeeding has been shown to provide a 
protective effect against respiratory infections compared to formula feeding in infants 
(Chantry et al. 2006; Duijts et al. 2010).  Breast milk plays several roles in regulating the 
immune system.  It provides signals to the immune system to help initial immune 
development (Kelly and Coutts 2000), contributes bioactive components such as 
cytokines and human milk oligosaccharides, and stimulates the release of cytokines in 
PBMC(Bessler et al. 1996).  Infants that are breastfed have also been shown to have 
increased natural killer cell counts (Grimble and Westwood 2001), higher antibody titers 
(Grimble and Westwood 2001), greater T helper cell phenotype development (Murphy et 
al. 2008), increased vaccination response (Dorea 2009) and lower morbidity and 
mortality rates (Kelly and Coutts 2000).   
The piglet is an excellent model in which to study development of the BALT, 
because they have similar immune and respiratory system physiology and development 
when compared to human infants.  In addition, piglets are susceptible to similar diseases 
and pathogens as humans (Haesebrouck and Pensaert 1986; Ito et al. 1998). Lastly, the 
pig can be easily reared independently of their mothers and can survive on bovine milk-
based sow-milk replacer formula, which provides an exceptional opportunity to screen 
potential additives to human infant formula.   
Piglets secrete defense proteins, peptides, cytokines and chemokines that are 
homologous to those of other mammals (Butler et al. 2009).  The lymphoid cell 
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populations in the pig are shown to be consistent to other vertebrates, especially humans 
(Boeker et al. 1999).  An exception is the fact that pigs express greater proportions of 
CD4+CD8+ double positive (DP) lymphocytes.  In pigs, this population comprises 
between 8 to 64% of the circulating pool of small resting T-lymphocytes (Pescovitz et al. 
1985; Pescovitz et al. 1994; Zuckermann and Husmann 1996; Zuckermann and Husmann 
1996) compared to <3%  in the human counterpart (Zuckermann 1999).  
In one analysis it was shown that infants who were fully breastfed for 4 to <6 
months were at greater risk for pneumonia than those who were fully breastfed for ≥ 6 
months (Chantry et al. 2006).  Another study showed that infants who were breastfed 
exclusively until 4 months of age and partially thereafter had lower risks of infections in 
the upper respiratory, lower respiratory and gastrointestinal tracts in infancy (Duijts et al. 
2010).  Approximately 80% of infants in the U.S. receive infant formula at some time in 
their first year of life.  Optimally, bovine milk-based formulas should be formulated to 
mimic, as closely as possible, the biological actions of breast milk on immune system 
development.  This is particularly important in achieving optimal development of 
mucosal immunity.  However, a detailed analysis of the development of the lungs and 
BALT of breast-fed and formula-fed infants is lacking.  The purpose of this study was to 
use the neonatal piglet model to gain a better understanding of the development of 
immune cellularity and cytokine expression in the lung and investigate the impact of 
neonatal nutrition by comparing SR and FF piglets.  This model then can be used to 
probe the effectiveness of various formula components on mucosal lung immune 
development.  In addition, peripheral blood cells and serum immunoglobulins were 
included as markers of systemic immune development.   
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Materials and Methods 
Chemicals 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless 
otherwise indicated.  
 
Dietary Treatment and Animal Protocol 
Piglets or sows were obtained from the Imported Swine Research Lab (ISRL) on 
the University of Illinois campus.  The formula fed (FF) piglets (n=11) were obtained at 
48 h postpartum to allow for consumption of colostrum.  They were transferred to ERML 
animal care facility.  Piglets were individually housed in environmentally controlled 
rooms (25°C) in cages, that maintain six piglets separated by Plexiglas partitions. Radiant 
heaters were attached to the tops of the cages to maintain an ambient temperature of 
30°C.  A commercially-available medicated sow milk-replacer formula (Advance Baby 
Pig Liquiwean, Milk Specialties Global Animal Nutrition, Carpentersville, IL) was 
provided as 14 equal feedings at a total volume of 360 ml/kg BW/day.  Sow-reared (SR) 
piglets (n=12) were vaginally-delivered and remained with their birth mother in an 
environmentally-controlled room at ERML.  Piglets were allowed to nurse ad libitum and 
were not given creep feed. However, by d21 piglets could be observed consuming small 
amounts of feed from the sow‟s bin.  All animal procedures were approved by the 
Institutional Animal Care and Use Committee of the University of Illinois. 
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Sample Collection 
On d7 (FF, n=5, SR, n=5) or d21 (FF, n=6, SR, n=7) postpartum, piglets were 
sedated with intramuscular injection of Telazol (3.5 mg/kg BW each tiletamine HCl and 
zolazepam HCl, Pfizer Animal Health, Fort Dodge, IA).  After sedation, blood was 
collected by cardiac puncture into non-coated vacutainer tubes (BD Biosciences, Franklin 
Lakes, NJ) for serum isolation.  Piglets were then euthanized by an intravenous injection 
of sodium pentobarbital (72 mg/kg BW Fatal Plus, Vortech Pharmaceuticals, Dearborn, 
MI).  After death, a thoracotomy was performed and mediastinal lymph nodes (MSLN) 
and thoracic lymph nodes (TLN) were quickly excised. A portion of the lung, MSLN and 
TLN were snap frozen in liquid nitrogen. The remaining MSLN and TLN were collected 
for isolation of mononuclear cells.  
 
Isolation and Phenotypic Identification of Mononuclear Cells from Tissues 
Mononuclear cells from TLN and MSLN were obtained by cutting tissues into 
pieces and dissociating using a GentleMACS Dissociator (Miltenyi Biotec, Auburn, CA).  
Cells then were sequentially passed through 100 µm and 40 µm cell strainers (BD 
Biosciences, Bedford, MA) to form single cell suspensions.  Cells were counted using a 
Countess automated cell counter (Invitrogen, Carlsbad, CA).  The number of viable cells 
was assessed by trypan blue (Invitrogen Gibco) exclusion.  The phenotype of T 
lymphocyte subpopulations from MSLN and TLN were monitored by flow cytometry 
using a panel of fluorescently labeled mAbs.  Lymphocytes were identified by anti-swine 
CD45 (Clone K252-1E4, AbD Serotec, Raleigh, NC).  Anti-CD45 was conjugated to 
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Alexa 647 with a Zenon Mouse Antibody Labeling Kit (Invitrogen Molecular Probes, 
Eugene, OR).  T lymphocytes were identified by mouse anti-pig CD3:biotin (Clone 
BB23-8E6, Southern Biotech, Birmingham, AL) that was visualized with 
streptavidin:PE-Cy7 (Southern Biotech). To further differentiate T cell populations, cells 
were stained with mouse anti-pig CD4:FITC (Clone 74-12-4, Southern Biotech) and 
mouse anti-pig CD8:PE (Clone 76-2-11, Southern Biotech). All staining procedures took 
place on ice and care was taken to prevent unnecessary exposure to light.  Briefly, one 
million cells per well were blocked with a mixture of 5% mouse serum (Southern 
Biotech) and 200 ug/ml purified mouse IgG (Invitrogen) for 5min. CD3 was added to the 
wells, incubated for 20 min, centrifuged, and then fluid was then aspirated. Cells were 
then incubated for 20 min in a total volume of 40 µl (10 µl of each: CD45, Strep-PECy7, 
CD4 and CD8). Cells were washed twice with PBS/1% BSA/0.1% sodium azide, and 
then fixed with 2% paraformaldehyde.  Staining was assessed using an LSRII flow 
cytometer (BD™, Biosciences, San Jose, CA).  The relative number of T cell 
subpopulations was determined using FlowJo 7.0 software (FlowJo, Ashland, OR).  
CD3+ events were considered T cells.  CD45+CD3+CD4+ events were considered T 
helper cells.  CD8+CD3+CD8+ events were considered cytotoxic T cells. NK cells were 
identified at CD3-CD4-CD8+ events. 
 
Cytokine Expression 
Total RNA was isolated and purified from snap frozen TLN, MSLN and lung 
samples with the TRIzol reagent (Invitrogen) following the manufacturer‟s protocol.  
RNA was quantified by spectrophotometry using a Nanodrop 1000 (Thermo Scientific, 
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Rockford, IL) at 260 nm.  RNA concentration was adjusted to 0.25 µg/ml using RNase 
free water (Invitrogen).  RNA quality was analyzed by a bioanalyzer (2100 Bioanalyzer, 
Agilent Technologies, Inc., Santa Clara, CA).  All samples had an RNA integrity number 
(RIN) greater than 6.0. 
Reverse transcription (RT) was performed on 3 μg of total RNA in a reaction 
involving 100 mM deoxyribonucleotide triphosphate (dNTP), 10X RT Buffer, 10X RT 
Random Primers, MultiScribe Reverse Transciptase, RNAse inhibitor (High Capacity 
cDNA Reverse Transcription Kit, Applied Biosystems, Foster City, CA) and 
Diethylpyrocarbonate-treated (DEPC) water (Invitrogen). The final RT product was 
quantified by spectrophotometry as above.  The final RT product was adjusted to a 
concentration of 1:150 or 1:200 using RNase-free water. Quantitative real-time PCR was 
conducted using SYBR-Green (Roche Diagnostics GmbH, Mannheim, Germany) and 
fluorescence intensity was collected using the Taqman ABI 7900 machine (Applied 
Biosystems Inc., Foster City, CA). A total of 40 PCR cycles were run.  The primers used 
are listed in Table 3.1, and final primer concentrations were 300nM.  Beta-actin was used 
as an internal standard reporter gene.  Results are expressed using the Relative Standard 
Curve Method.  In short, serial dilutions from a stock of pooled porcine spleen cDNA 
(range: 1:5 to 1:15,625) were made and run on each plate. Each sample was run with 
primers to assess the target gene and beta-actin. Normalized values for each target were 
calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold-
difference was calculated for each measurement by dividing the normalized target values 
by the normalized calibrator sample (in this case the formula fed group average). All 
samples that were statistically compared to each other were run on the same plate.  
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Isolation of Mononuclear Cells from Peripheral Blood 
Peripheral blood mononuclear cells (PBMC) were isolated by density gradient 
centrifugation.  Briefly 10 ml of heparinized blood was diluted in 25 ml of RPMI and 
layered over Ficoll-Paque PLUS lymphocyte separation medium (GE Healthcare, 
Uppsala, Sweden). The peripheral blood mononuclear cells (PBMC) were recovered after 
centrifugation (400 x g, 30 min) across the density gradient.  Isolated PBMC were placed 
in complete culture medium (RPMI 1640 (Gibco Invitrogen, Grand Island, NY) 
containing 10% fetal calf serum (Gibco Invitrogen, Grand Island, NY), 2 mM L-
glutamine, 100 μg/ml penicillin, 100 μg/ml streptomycin, and 50 μg/mL gentamycin). 
 
Serum Immunoglobulin Levels 
Total serum immunoglobulin levels were detected by ELISA using assays specific 
for porcine IgG, IgM and IgA Quantification Sets (Bethyl Laboratories, Montgomery, 
TX, USA).  A 96-well, flat-bottomed ELISA plate (Nunc, Rochester, NY) was coated 
with 100 µl coating antibody (µg coating antibody as suggested by the manufacturer 
diluted in 0.05M carbonate-bicarbonate buffer, pH 9.6) and incubated overnight at 4°C. 
The antibody solution was poured off, and the plate was washed three times with 
PBS/0.05% Tween20.  The plates were blocked with 300 µl of 3% BSA/PBS for 1 h at 
room temperature (RT). The plates were washed as before. Serum samples were serially 
diluted in 0.05% gelatin/PBS, added to the wells in duplicate (100 µl per well), and plates 
were incubated for 1 h at RT. Samples for standard curves were included with the 
quantification sets and were used as directed.  Plates were washed as before, and 100 µl 
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HRP-conjugated detection antibody (concentration as recommended by the manufacturer) 
in 0.05% gelatin/PBS was added to each well.  Plates were protected from light and 
incubated for 1 h at RT.  Plates were washed four times with PBS-Tween 20. 100 µl 
TMB reagent solution (OptEIA, BD Biosciences, San Diego, CA) was added to each well 
and allowed to develop protected from light at RT for the time recommended by the 
manufacturer.  The reaction was stopped with 100 µl 2N H2SO4 per well.  The 
absorbance was then read at 450 nm with 570 nm correction using a microplate reader 
(SpectraMax M2
e
, Molecular Devices, Sunnyvale, CA). Total immunoglobulin values 
were determined based on a standard curve that was run on each plate. 
 
Statistical Analysis 
Analyses were performed using the PROC GLM (generalized linear model) 
procedure within SAS (Version 9.2, SAS Institute, Cary, NC).  The initial model was 
day, diet and day*diet interaction.  If the model was not significant, d7 and d21 data were 
combined.  If diet was not significant, diet was excluded and SR and FF at d7 data were 
combined and SR and FF at d21 were combined.  Statistical significance was defined as 
p<0.05, with trends reported as p<0.10.  All data are expressed as mean ± SD.   
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Results 
T Lymphocyte Populations  
 Flow cytometry was used to analyze T cell phenotype as well as NK cells in 
PBMC, MSLN and TLN.  PBMC NK cell populations and CD4:CD8 ratios did not differ 
between SR and FF piglets, thus SR and FF samples were pooled at both d7 and d21 in 
order to make developmental comparisons. CD4+CD8+ double positive T cell data were 
not pooled because the model was significant.  There were more CD4+CD8+ double 
positive T cells in the PBMC populations from d21 pigs than d7 pigs (p<0.05) (Figure 
3.1A). NK cells were higher in the PBMC populations from d7 than those from d21 
piglets (p<0.05) (Figure 3.1B).  CD4:CD8 ratios did not differ between d7 and d21 
piglets.  Thus, diet did not significantly affect developmental profiles of T cell and NK 
cells in PBMC. 
This was not true in the BALT.  On d7, MSLN CD4:CD8 T cell ratios did not 
differ between SR and FF pigs.  By d21, CD4:CD8 T cell ratios were higher (p<0.0001) 
in SR (7.9 ± 1.7%) than in FF piglets (4.2 ± 1.3%) at d21 (p<0.0001) (Figure 3.2).  
CD4+CD8- T cells were higher (p<0.05) at d7 than d21 and CD4+CD8- T cells were 
higher (p<0.05) in SR compared to FF piglets (Figure 3.3A).  CD4-CD8+ T cells were 
higher (p<0.01) at d21 than d7 (Figure 3.3B).  FF piglets had more double positive T 
cells compared to SR piglets (p<0.01) (Figure 3.4).  NK cells were not significantly 
different between SR and FF piglets in MSLN at either age.  
Diet effects were also observed in the TLN T cell populations.  These effects, 
however, were observed earlier than those in the MSLN.  Day 7 TLN CD4:CD8 T cell 
ratios were higher (p<0.05) in SR (10.5 ± 2.6%) than FF piglets (6.7 ± 1.9%) (p<0.05) 
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(Figure 3.5A).  Additionally, d7 TLN double positive CD4+CD8+ T cells were higher 
(p<0.05) in SR (9.9 ± 0.02%) than in FF piglets (7.4 ± 0.01%) (Figure 3.5B).  There 
were no differences between FF and SR groups for CD4:CD8 T cell ratio (p=0.09) or 
percentages of CD4+CD8+ T cells (p=0.28) in TLN at d21.  Diet and developmental 
changes were observed in CD4-CD8+ T cells; CD8+ T cells were higher (p<0.01) at d21 
than d7 and FF were greater (p<0.01) than SR (Figure 3.6).  There were no differences in 
CD4+CD8- T cell populations.  Diet also affected NK cells; NK cells were higher 
(p<0.05) in SR (7.4 ± 2.8%) than in FF piglets (3.4±3.1%) (Figure 3.7). 
 
Cytokines mRNA Expression 
 The mRNA expression of various genes was investigated in whole tissue samples 
from the lung, TLN and MSLN in order to gain a better understanding of gene expression 
profiles in these tissues (see Table 3.2 for a summary of the roles of these 
cytokines/receptor).  No differences were observed between FF and SR piglets in mRNA 
expression of IL-6, TGF-β1, IFN-α, IFN-β or TGF-β2 in TLN. However, there were 
developmental differences seen in the expression of IL-12 (Figure 3.8A) and dectin 
(Figure 3.8B), as well as, diet effects for IL-1β (Figure 3.9A), and TNF-α (Figure 3.9B) 
expression.  TLN IL-12 and dectin mRNA were higher (p<0.05) at d7 than at d21.  TLN 
IL-1β and TNF-α were higher (p<0.05) in FF animals than in SR animals.  
In MSLN, mRNA expression of IL-6, IL-12, TGF-β1, IL-1β, IFN-β, and TNF-α 
were not significantly different between SR and FF piglets.  However, dectin mRNA 
expression was higher (p<0.01) in FF compared to SR piglets (Figure 3.10A).  Dectin 
expression also tended (p=0.051) to be decreased from d7 to d21.  A day*diet interaction 
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was also significant (p<0.05) in mRNA expression of dectin. TGF-β2 and IFN-α mRNA 
expression were higher (p<0.05) in FF compared to SR piglets (Figures 3.10B and 3.11).   
In lung, mRNA expression of dectin, IL-12, TGF-β2, and IL-1β were not 
significantly different between SR and FF piglets.  However, IL-6 (Figure 3.12A), TGF-
β1 (Figure 3.12B), TNF-α (Figure 3.13A), and IFN-α (Figure 3.13B) mRNA expression 
were higher (p<0.05) at d21 than at d7.  IFN-β mRNA expression was higher (p<0.05) in 
FF piglets compared to SR piglets (Figure 3.14).  (See Table 3.3 for a summary of 
cytokine/receptor results.) 
 
Total Serum Immunoglobulin Levels 
In order to determine if circulating immunoglobulins differed in SR and FF 
piglets, sera from both groups were analyzed for IgG, IgM, and IgA concentrations at d7, 
d14 and d21.  The serum IgG concentrations were lower (p<0.05) in the SR piglets when 
compared to the FF piglets.  IgG concentrations in d7 animals were higher (p<0.05) than 
in d14 and d21 animals (Figure 3.15).  Serum IgG concentrations ranged from 16.0 ±7.9 
mg/ml to 26.1 ± 12.4 mg/ml in d7, whereas d14 ranged from 12.6 ± 4.8 mg/ml to 15.3 ± 
5.2 mg/ml.  Day 21 total serum IgG ranged from 9.5 ± 4.3 mg/ml to 15.2 ± 10.2 mg/ml.  
Serum IgM levels were not significantly different in SR piglets compared to FF piglets. 
Day 7 total serum IgM ranged from 6.8 ± 3.0 mg/ml to 11.9 ± 4.4 mg/ml while day 14 
was 10.3 ± 4.6 mg/ml to 13.0 ± 7.6 mg/ml, and d21 ranged from 7.6 ± 1.6 mg/ml, to 12.2 
± 3.7 mg/ml. The serum IgA concentrations were lower in the SR piglets when compared 
to the FF piglets (p<0.05), while IgA concentrations on d7 animals were higher than 
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those on d14 and d21 (p<0.05) (Figure 3.16).  Serum IgA concentrations averaged 2.5 ± 
1.2 mg/ml at d7, 0.5 ± 0.4 mg/ml at d14, and 0.2 ± 0.1 mg/ml at d21.  
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Discussion 
The immune system is functionally immature at birth, the immediate postnatal 
period and during weaning are the developmental periods when the neonate is subjected 
to a vast array of potentially pathogenic microorganisms, especially respiratory 
infections, that were not encountered in utero or during the first few months of life, 
respectively.  At these especially vulnerable times in the neonate‟s life, highly complex 
pathways of recognition, response, elimination and memory are important in order to help 
protect the host (Calder et al. 2006).  Composition of the diet influences the development 
and competence of the immune system (Volman et al. 2008).  In this study, we examined 
developmental differences in the BALT of SR and FF piglets.  
Flow cytometry was used to assess immune development by characterizing the T 
cell subpopulations and NK cells present in PBMC, TLN and MSLN. Hawkes and 
colleagues compared PBMC from breast-fed and formula-fed human infants at 6 months 
of age.  They found that the relative frequency of NK cells was greater in breast-fed than 
in formula-fed infants (9.7% vs. 7.1%; p < 0.001) (Hawkes et al. 1999).  The population 
of NK cells within the PBMC in our study was not significantly different between SR 
was compared to FF, but were observed to decrease over time.  In the same study, 
Hawkes and co-workers found that the CD4:CD8 ratio in breast-fed infants was lower 
than that in formula-fed infants (2.8 vs. 3.3; p < 0.005) (Hawkes et al. 1999). In contrast, 
the results of our study found that the CD4:CD8 ratio was not statistically different in SR 
compared to FF PBMC.  However, the CD4:CD8 ratio was higher in SR piglets 
compared to FF piglets at d21 in MSLN and at d7 in TLN.   
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As expected (Zuckermann 1999), CD4+CD8+ double positive T lymphocytes 
increased from d7 to d21 in PBMC.  While MSLN CD4+CD8+ double positive T 
lymphocytes were higher in FF piglets compared to SR piglets at d21, TLN CD4+CD8+ 
cells were higher in SR compared to FF piglets at d7.  One possible explanation is that 
the TLN and MSLN drain different internal structures possibly resulting in varying levels 
of expression. 
In both humans and swine, neonates are born with an impaired production of TH1-
cell associated cytokines due to a maternal TH2 bias during pregnancy that protects the 
fetus from immune response or rejection (Calder et al. 2006).  This TH2 bias creates TH2 
dominance in the fetus.  Because this comes at the expense of TH1 cytokine production, it 
leaves the newborn susceptible to microbial infection.  Additionally, if the neonate is not 
able to effectively down-regulate the pre-existing TH2 dominance and overcome low 
levels of allergen-specific IgE antibodies, an allergic phenotype may develop (Calder et 
al. 2006).   
In order to gain an overview of cytokine production in the lungs of SR versus FF 
piglets, mRNA expression was analyzed.  This analysis included TH1-associated 
cytokines (interleukin (IL)-12), pro-inflammatory cytokines (IL-6 and TNF-α), and TH3 
cytokines (TGF-β1, and TGF-β2).  Expression of both dectin and IL-12 decreased over 
time in TLN.  This may correspond with an initial aggressive attempt to establish TH1 
development, once a balance has been created between TH1 and TH2 expression the drive 
to establish this switch is decreased resulting in decreased expression of both dectin and 
IL-12.  Expression of IL-6, TGF-β1, TNF-α, and IFN-α in lung all increased overtime as 
expected.  These cytokines likely increased over time due to greater exposure of the lung 
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to various antigens. IL-1β, and TNF-α in TLN, dectin, TGF-β2, and IFN-α  in MSLN, as 
well as IFN-β in lung all had greater expression in FF animals compared to SR animals.  
Perhaps this is due to stress associated with birth and subsequent separation from their 
mother a birth, or perhaps this pattern is due to an underlying inflammation since the FF 
piglets are less protected from environmental pathogens than the SR counterpart.  These 
differences in expression could also be due to the differences in colostrum each piglet 
received. 
In each tissue, we saw differing patterns of cytokine mRNA expression.  These 
differences could be due to location of each tissue in the body and the proximity of each 
tissue to pathogens.  Lung tissue would likely be the furthest target on the pathogen‟s 
route from the oral/naso-pharynx route into the body.  Thus, lung tissue would be 
exposed to fewer foreign microorganisms leading it to mount a different type of immune 
response than the MSLN, which are closer to the point of airway branching and therefore 
in closer proximity to the foreign microorganisms route of entry.   TLN are located 
superior to both the lung and MSLN and, therefore, encounter pathogens before the 
others in the course of ingestion/inhalation. TLN and MSLN also drain different internal 
structures and may therefore be exposed to different organisms causing dissimilar 
strengths of expression. Each lymph node excised in the TLN and MSLN groups differ in 
its location and therefore each may differ in level of expression thus causing noticeable 
variation around the mean.   
To gain a perspective of systemic immune development of piglets in each of the 
dietary treatment groups, total serum IgG, IgM and IgA concentrations were measured.  
We found that the serum IgG concentrations were lower in the SR piglets when compared 
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to the FF piglets (p<0.05). Overall, IgG concentrations were higher on d7 than on d14 
and d21 (P<0.05). Previous research suggested that concentrations of IgG in colostrum 
decrease 5-fold in the first 24 h of lactation and then IgG concentration in the sow‟s milk 
decreases 30-fold in the first week (Bourne 1973).  The IgG concentrations in serum of 
young piglets followed this same pattern (Bourne 1973).  It is likely that the sows that 
nursed the piglets that were eventually FF provided varying levels of IgG that 
subsequently created variation in immunoglobulin levels in the piglet serum.  
Serum IgM concentrations were not significantly different in SR piglets compared 
to FF piglets. Bourne‟s research suggests that concentrations of IgM in colostrum 
decrease 2-fold in the first 24 h of lactation and then drop slightly through the course of 
the next 35 days (Bourne 1973). The IgM concentrations in the serum of young piglets 
decreased rapidly following the first 24 h of life to their lowest level at 8-14 d of age.  
IgA then began to increase (Bourne 1973).  
Serum IgA concentrations were lower in the SR piglets when compared to the FF 
piglets (p<0.05). Overall, IgA serum concentrations were higher on d7 than on d14 and 
d21 (P<0.05). Bourne‟s research suggests that concentrations of IgA in colostrum 
decrease 3-fold in the first 24 h of lactation and then tend to fluctuate through the course 
of the next 35 days of age (Bourne 1973). The IgA concentrations in serum of young 
piglets varied in the first 24 h but then decreased rapidly after 24 h to their lowest values 
at 17-22 d of age (Bourne 1973).  Curtis and Bourne concluded, based on half-life studies 
of naturally absorbed colostral immunoglobulins and 
125
I-labelled immunoglobulins, that 
IgA production in the piglet did not contribute significantly to serum IgA concentrations 
in the first 7-12 d of life nor did IgG production during the first 2-3 weeks of life.  
42 
 
However, IgM produced in the first week of life contributed significantly to circulating 
IgM levels (Bourne and Curtis 1973). Ogawa and co-workers found that TGF-β1 and 
TGF-β2 in colostrum correlated with increased serum IgA concentrations in human 
infants during the first month of life (Ogawa et al. 2004).  It was also found that high 
concentrations (10 ng/ml) of TGF-β1 suppressed immunoglobulin-secreting cell 
responses to LPS and rotavirus while low concentrations (0.1 ng/ml) promoted isotype 
switching to IgA antibody (Nguyen et al. 2007). 
It has been generally recognized that infants who are breast-fed have fewer 
infections compared with those who are formula fed.  There is consistent evidence, in 
both developed and developing countries, that breast-feeding provides a protective effect 
in the first 4-6 months of life (Golding et al. 1997).  Maternal colostrum and milk, in 
addition to supplying the neonate with nutrition, also protect against gastrointestinal and 
respiratory diseases (Kelly and Coutts 2000) and have been shown to promote the 
maturation of the developing intestinal epithelium (Burrin et al. 1992; Wang and Xu 
1996).    
In conclusion, this research supports previous research that diet does, in fact, 
impact immune development.  This research helps identify some of the lung-specific 
immunological differences associated with diet and development.  Thus, this study has 
established a set of baseline measurements from which it will be possible to look at 
effects of pathogens or other insults to the system as well as dietary components that may 
bring the FF piglets bronchial-associated immune development more in line with that 
seen in the SR piglets.  Through this study, we have established a foundation of 
normative changes over time for future studies to probe effectiveness of various formula 
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components on mucosal lung immune development and to identify potential effects of 
diet in a respiratory challenge model.  These challenge experiments will determine if the 
difference in immune development seen in piglets fed sow-milk replacer or sow‟s milk 
itself affects the neonate‟s ability to resist respiratory infections or enables them to 
recover more quickly. 
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Table 3.1: Primers Used for Quantitative Real Time-PCR. 
 
Gene Forward Primer (5‟ to 3‟) Reverse Primer (5‟ to 3‟) Gene Bank Accession ID 
β-actin CACGCCATCCTGCGTCTGGA AGCACCGTGTTGGCGTAGAG DQ845171.1 
Dectin CTCTCACAACCTCACCAGGAGAT CAGTAATGGGTCGCCAATAAGG FJ386384.1 
IL-12 CGTGCCTCGGGCAATTATAA CAGGTGAGGTCGCTAGTTTGG NM_213993.1 
IL-6 CTGGCAGAAAACAACCTGAACC TGATTCTCATCAAGCAGGTCTCC AB194100.1 
IL-1β AACGTGCAGTCTATGGAGT GAACACCACTTCTCTCTTCA NM_214055.1 
IFN-α TCTCATGCACCAGAGCCA CCTGGACCACAGAAGGGA NM_001166311.1 
IFN-β AGTGCATCCTCCAAATCGCT GCTCATGGAAAGAGCTGTGGT GQ415073.1 
TGF-β1 CCTGCAAGACCATCGACATG GCCGAAGCTTGGACAGAATC AF461808.1 
TGF-β2 TGTGTGCTGAGCGCTTTTCT GAGCGTGCTGCAGGTAGACA L08375.1 
TNF-α AACCTCAGATAAGCCCGTCG ACCACCAGCTGGTTGTCTTT EU682384.1 
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Figure 3.1: T cells and NK cells in PBMC.  Samples were analyzed by flow cytometry, as described in Materials and Methods.  SR 
and FF NK cells in PBMC were not significantly different; thus, both day 7 SR and FF samples were pooled and day 21 SR and FF 
samples were pooled for statistical analysis of NK cells.  Data are presented as mean ± SD. Data with different letters are significantly 
different (p<0.01).  A) PBMC CD45+CD3+CD4+CD8+ T cells were significantly higher at d21 compared to d7. B) NK cells 
were significantly higher at d7 compared to d21 (p<0.05). 
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Figure 3.2: MSLN CD4:CD8 T cell ratios CD4+CD8+ cells are significantly different on d21 but not on d7.  Piglets were 
euthanized on d7 or d21.  MSLN were collected.  Cells were isolated and stained with a panel of fluorescently labeled mAb including 
CD45, CD3, CD4, and CD8.  Data are expressed as mean ± SD.  Data with different letters are significantly different (p<0.05).  
MSLN CD4:CD8 T cell ratios were significantly higher in SR compared to FF on d21 (p=0.0256).  The overall model was 
significant and d7 was higher than d21 (p<0.1) and a day x diet interaction (p<0.05).  Data are presented as CD4+events: CD8+ events 
ratio as a percentage of CD45+CD3+ lymphocytes.  
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Figure 3.3: MSLN CD4+CD8- T cells are significantly higher at d7 than d21 and in SR compared to FF while CD4-CD8+ T 
cells are significantly higher at d21 than d7.  Piglets were euthanized on d7 or d21.  MSLN were collected.  Cells were isolated and 
stained with a panel of fluorescently labeled mAb including CD45, CD3, CD4, and CD8.  Data are expressed as mean ± SD.  Data 
with different letters are significantly different (p<0.05).  A) MSLN CD4+CD8- T cells were higher on d7 than d21.  CD4+CD8- 
were also higher in SR compared to FF animals.  B) MSLN CD4-CD8+ T cells were higher on d21 than d7. 
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Figure 3.4: MSLN CD4+CD8+ cells are significantly higher in FF compared to SR.  Piglets were euthanized on d7 or d21.  
MSLN were collected.  Cells were isolated and stained with a panel of fluorescently labeled mAb including CD45, CD3, CD4, and 
CD8.  Data are expressed as mean ± SD.  Data with different letters are significantly different (p<0.05).  MSLN 
CD45+CD3+CD4+CD8+ T cells were significantly higher in FF piglets compared to SR (p<0.01). 
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Figure 3.5: TLN CD4:CD8 T cell ratios and CD4+CD8+ cells are significantly different on d7 but not on d21. Piglets were 
euthanized on d7 or d21.  TLN were collected.  Data are expressed as mean ± SD.  Data with different letters are significantly different 
(p<0.05).   A) TLN CD4:CD8 T cell ratios were significantly higher in FF than SR piglets at d7 (p=0.028).  Data are expressed as 
CD4+events: CD8+ events ratio as a percentage of CD45+CD3+ lymphocytes. B) TLN CD4+CD8+ T cells were significantly 
higher in SR than FF piglets at d7 (p= 0.023).  
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Figure 3.6: TLN CD4-CD8+ T cell populations were greater in FF compared to SR and were higher at d21 than d7. Piglets 
were euthanized on d7 or d21.  TLN were collected.  Data are expressed as mean ± SD.  Data with different letters are significantly 
different (p<0.05).  TLN CD4-CD8+ T cell populations were significantly higher in FF than SR piglets and were higher at d21 
than d7.  
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Figure 3.7: TLN NK cells are significantly higher in SR compared to FF piglets. Piglets were euthanized on d7 or d21.  TLN were 
collected.  Data are expressed as mean ± SD.  Data with different letters are significantly different (p<0.05).   NK cells are CD4-CD8+ 
events as a percentage of CD3- events. 
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Table 3.2: Summary of the roles of cytokines/receptor. 
 
 
Gene/Receptor Major Roles 
IL-12 TH1-cell development activation
1
 
Dectin Pattern recognition receptor, binds fungal species
2
, 
role phagocytosis of apoptotic cells
2
, mediates 
production of various cytokines and chemokines
2
, 
stimulation of Dectin drives TH1 development
2
 
IL-1β Phagocyte activation1, increases endothelial adhesion 
molecules
1
, T-cell and macrophage activation
1
 
TNF-α Promotes inflammation and endothelial activation
1
, 
early inflammatory cytokine 
TGF-β1 Inhibits cell growth and induces switch to IgA 
production
1
, regulatory cytokine 
TGF-β2 Promotes oral tolerance 
IL-6 Lymphocyte growth and B-cell differentiation
1
, early 
inflammatory cytokine  
IFN-α Antiviral, increased MHC class I expression
1
 
IFN-β Antiviral
1
, increased MHC class I expression
1
 
 
1
(Murphy et al. 2008)
  2
(Willment and Brown 2010)
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Figure 3.8: IL-12 and Dectin mRNA expression in TLN.  Piglets were sow-reared or formula-fed and euthanized on d7 or d21.  
TLN were excised and snap frozen.  TLN mRNA was isolated, purified, and quantified using qRT-PCR.  Normalized values for each 
target gene were calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold difference was calculated for 
each measurement by dividing the normalized target values by the average normalized target value for day 7 formula fed animals. All 
samples that were statistically compared to each other were run on the same plate.  Data are expressed as mean ± SD of the fold 
difference relative to formula-fed animals.  Data with different letters are significantly different (p<0.05).  A) IL-12 mRNA 
expression in TLN was greater on d7 than on d21. B) Dectin mRNA in TLN was higher on d7 than on d21.   
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Figure 3.9: IL-1β and TNF-α mRNA expression in TLN.  Piglets were sow-reared or formula-fed and euthanized on d7 or d21.  
TLN were excised and snap frozen.  TLN mRNA was isolated, purified, and quantified using qRT-PCR.  Normalized values for each 
target gene were calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold difference was calculated for 
each measurement by dividing the normalized target values by the average normalized target value for day 7 formula fed animals. All 
samples that were statistically compared to each other were run on the same plate.  Data are expressed as mean ± SD of the fold 
difference relative to formula-fed animals.  Data with different letters are significantly different (p<0.05).  A) TLN IL-1β expression 
was higher in formula-fed animals than in sow-reared animals.  B) TLN TNF-α expression was higher in formula-fed animals 
than in sow-reared animals. 
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Figure 3.10: Dectin and TGFβ-2 mRNA expression in MSLN.  Piglets were sow-reared or formula-fed and euthanized on d7 or 
d21.  TLN were excised and snap frozen.  MSLN mRNA was isolated, purified, and quantified using qRT-PCR.  Normalized values 
for each target gene were calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold difference was 
calculated for each measurement by dividing the normalized target values by the average normalized target value for day 7 formula 
fed animals. All samples that were statistically compared to each other were run on the same plate.  Data are expressed as mean ± SD 
of the fold difference relative to formula-fed animals.  Data with different letters are significantly different (p<0.05).  A) Dectin 
mRNA expression was higher in formula fed piglets compared to sow reared piglets and was trending towards a difference in 
day where d7 was higher than d21 (p=0.0505).  Day*diet interaction was also significant.   B) TGFβ-2 mRNA expression was 
significantly higher in formula fed piglets compared to sow reared piglets. 
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Figure 3.11: IFN-α mRNA expression in MSLN.  Piglets were sow-reared or formula-fed and euthanized on d7 or d21.  TLN were 
excised and snap frozen.  MSLN mRNA was isolated, purified, and quantified using qRT-PCR.  Normalized values for each target 
gene were calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold difference was calculated for each 
measurement by dividing the normalized target values by the average normalized target value for day 7 formula fed animals. All 
samples that were statistically compared to each other were run on the same plate.  Data are expressed as mean ± SD of the fold 
difference relative to formula-fed animals.  Data with different letters are significantly different (p<0.05).  IFN-α mRNA expression 
was significantly higher in formula fed piglets compared to sow reared piglets. 
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Figure 3.12: IL-6 and TGFβ-1 expression in Lung.  Piglets were sow-reared or formula-fed and euthanized on d7 or d21.  Lung 
were excised and snap frozen.  Lung mRNA was isolated, purified, and quantified using qRT-PCR.  Normalized values for each target 
gene were calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold difference was calculated for each 
measurement by dividing the normalized target values by the average normalized target value for day 7 formula fed animals. All 
samples that were statistically compared to each other were run on the same plate.  Data are expressed as mean ± SD of the fold 
difference relative to formula-fed animals.  Data with different letters are significantly different (p<0.05).  A) IL-6 mRNA expression 
was higher at d21 compared to d7.  B) TGF-β1 mRNA expression was higher at d21 compared to d7.   
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Figure 3.13: TNF-α and IFN-α mRNA expression in Lung.  Piglets were sow-reared or formula-fed and euthanized on d7 or d21.  
Lung tissue were excised and snap frozen.  Lung mRNA was isolated, purified, and quantified using qRT-PCR.  Normalized values 
for each target gene were calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold difference was 
calculated for each measurement by dividing the normalized target values by the average normalized target value for day 7 formula 
fed animals. All samples that were statistically compared to each other were run on the same plate.  Data are expressed as mean ± SD 
of the fold difference relative to formula-fed animals.  Data with different letters are significantly different (p<0.05).  A) TNF-α 
mRNA expression was higher on d21 compared to d7.  B) INF-α mRNA expression was higher on d21 compared to d7.   
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Table 3.3: Summary of cytokine/receptor results. 
 
 
Tissue Cytokine/Receptor Day Diet Interaction 
TLN IL-12 7>21 None No 
TLN Dectin 7>21 None Yes 
TLN IL-1β None FF>SR No 
TLN TNF-α None FF>SR No 
MSLN Dectin None FF>SR No 
MSLN TGF-β2 None FF>SR No 
MSLN IFN-α 7>21 None No 
Lung IL-6 7<21 None No 
Lung TGF-β1 7<21 None No 
Lung TNF-α 7<21 None No 
Lung IFN-α 7<21 None No 
Lung IFN-β None FF>SR No 
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Figure 3.14: IFN-β mRNA expression in lung.  Piglets were sow-reared or formula-fed and euthanized on d7 or d21.  Lung 
tissue sections were excised and snap frozen.  Lung mRNA was isolated, purified, and quantified using qRT-PCR.  Normalized 
values for each target gene were calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold 
difference was calculated for each measurement by dividing the normalized target values by the average normalized target 
value for day 7 formula fed animals. All samples that were statistically compared to each other were run on the same plate.  
Data are expressed as mean ± SD of the fold difference relative to formula-fed animals.  Data with different letters are 
significantly different (p<0.05). IFN-β mRNA expression was higher in FF compared to SR piglets. 
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Figure 3.15: Serum IgG concentrations in SR and FF piglets.  Sera were collected on day 7, 14, and 21. Data are expressed 
as mean ± SD.  Serum IgG concentrations were lower in the SR piglets when compared to the FF piglets.  IgG 
concentrations on day 7 were higher than on day 14 and day 21. 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
40
45
50
d7 d14 d21
T
o
ta
l I
gG
 (
m
g/
m
l)
 
Formula Fed Sow Reared
Model: p = 0.04 
Day: p = 0.047 
Diet: p = 0.03 
Interaction: p = 0.59 
62 
 
Figure 3.16: Serum IgA concentrations in SR and FF piglets.  Sera were collected on day 7, 14, and 21. Data are expressed 
as mean ± SD.  Serum IgA concentrations were lower in the SR piglets when compared to the FF piglets.  IgA 
concentrations on day 7 were higher than on day 14 and day 21. 
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Chapter 4 
Dietary Yeast β-glucan Minimally Impacts Development of Lung Immunity in the 
Neonatal Piglet 
 
Abstract 
Purified yeast (1,3/1,6)-β-D-glucan (WGP) has been shown to enhance immune 
responsiveness. Herein, the hypothesis that WGP would modulate the lung immune 
development and improve influenza vaccination response was tested.  Piglets (n=5-
6/group) were fed formula containing 0 (control), 5 (WGP5), 50 (WGP50), or 250 
(WGP250) mg/L formula.  Half of the piglets in each treatment were vaccinated (FV) by 
i.m. injection against influenza (Fluzone™, Sanofi Pasteur, Swiftwater, PA) on d7 and 
received a booster on d14. Piglets were euthanized on d7 and d21. Weight gain and 
formula intake were unaffected by diet or vaccination. Fluzone-specific serum IgG 
concentrations was measured by ELISA.  FV piglets had higher (p<0.0001) fluzone-
specific IgG titer at d14 and 21 than non-V piglets independent of diet. Vaccination 
response were unaffected by oral WGP supplementation.  TNF-α, dectin, IL-1α, -2, -4, 
and -12 mRNA expression in lung were unaffected by age or dietary WGP.  Lung TGFβ-
1 mRNA expression was greater (p<0.05) at d21 than d7, and lung TGFβ-2 mRNA was 
lower (p<0.01) in all WGP diets compared to control. TNF-α, dectin, TGFβ-1, IL-2, -4, -
6, or -12 mRNA in mediastinal lymph nodes (MSLN) were unaffected by age or dietary 
WGP. In MSLN, TGFβ-2 mRNA expression increased from d7 to d21 (p<0.05).  TNF-α, 
TGFβ-1, TGFβ-2, IL-4, -6, or -12 mRNA in thorasic lymph nodes (TLN) were unaffected 
by age or dietary WGP.  Dectin mRNA expression in TLN was lower at d21 compared to 
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d7 (p<0.05). T-cell phenotypes were examined in MSLN and TLN by flow cytometry.  In 
MSLN and TLN, CD4+ T-cells decreased, while CD8+ T-cells increased between d7 and 
d21 piglets (p<0.001), but these developmental patterns were unaffected by dietary WGP.  
Total serum IgG, IgM and IgA concentrations were also analyzed via ELISA.  Total 
serum IgG, IgM and IgA were unaffected by WGP but followed typical developmental 
patterns.  Thus, with the exception of reducing TGFβ-2 mRNA in lung, dietary WGP did 
not affect cytokine expression, T-cell phenotypes or vaccination response in piglets. 
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Introduction 
A continuing challenge in medicine today is finding the optimal diet for an infant 
who is unable to breastfeed.  Thus, the identification and characterization of compounds 
that enhance the growth, development and health of those infants continues to be a goal 
for nutritional science.  Newborns are transitioning into a world rich in foreign 
substances.  They must rapidly develop immune protection to defend against infection 
while avoiding harmful inflammatory responses.  Their immune systems develop in 
response not only to innate developmental signals, but also to signals from commensal 
bacteria and dietary components (Kelly and Coutts 2000). Herein, we explore the effects 
of one dietary component, yeast β-glucan (βG), on lung immune system development 
using the neonatal piglet as a model for human infants. 
Β-glucans are polysaccharides that occur as a principal component of cellular 
walls in  yeast, fungi, seaweeds, mushrooms, and some cereals such as oats and barley. β-
(1,3)-glucans belong to the group of Biological Response Modifiers (BRM) meaning that 
they do not have direct cytotoxic activities but are able to boost the natural defense 
mechanisms of the host. The immune system identifies βG by signaling through pattern-
recognition receptors (PRR) present on immune cells.  These PRRs include at least four 
receptors including dectin-1, complement receptor 3 (CR3; CD11b/CD18), 
lactosylceramide receptors, and scavenger receptors (Descroix et al. 2006). Through 
these receptors βG stimulate the innate immune system as well as modulate humoral and 
cellular immunity and may improve an individual‟s ability to fight infections 
(Mahauthaman et al. 1988; Saito et al. 1992; Adachi et al. 1994; Zhang and Petty 1994; 
Lebron et al. 2003). 
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The first point of contact for inhaled substances such as environmental pollutants, 
cigarette smoke, airborne allergens, and microorganisms is the epithelial lining of the 
upper airways and lungs (Diamond et al. 2000).  Therefore, mucosal defense mechanisms 
are critical in preventing colonization of the respiratory tract by pathogens and 
penetration of antigens through the epithelial barrier.  In recent years, it has become clear 
that airway epithelial cells not only function as a passive barrier, but also actively 
participate in innate immune responses (Diamond et al. 2000; Holgate et al. 2000).  One 
of the ways by which is it posited they do this is through PRR signaling which in turn 
regulates the expression of a variety of genes including cytokines and chemokines.  In 
fact, airway epithelial cells have been shown to secrete a large variety of molecules that 
are involved in inflammatory and immune processes including cytokines, chemokines, 
leukotrienes, calprotectin, β-defensins and other factors (Diamond et al. 2000; Holgate et 
al. 2000; Bals and Hiemstra 2004).  Through the secretion of these substances, the airway 
epithelium is able to chemoattract and activate cells of the innate and adaptive immune 
system, to immobilize and kill microorganisms, to induce would healing and 
angiogenesis in response to injury and to orchestrate the initiation of and adaptive 
immune response (Bals and Hiemstra 2004). 
β-D-Glucans have mixed effects on lung function and airway responsiveness.  
Generally, they appear to protect against microbial challenges. In one study, 
Saccharmyces cerevisiae βG fed orally (50 mg/day/pig) reduced the pulmonary lesion 
score and viral replication rate of pneumonia induced by swine influenza virus (SIV) in 
piglets (Jung et al. 2004).  In another study, yeast β-(1,3)-glucan administered by 
subcutaneous injection increased survival rate, diminished bacterial load in the lungs and 
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increased the proportion of bacteria-free animals after infection with anthrax in mice 
(Kournikakis et al. 2003). Yeast βG also had an anti-viral effect against porcine 
reproductive and respiratory virus (PPRS) in weanling pigs and was associated with an 
up-regulation of the TH1 cytokine IFN-gamma (Xiao et al. 2004).  In contrast, pigs fed 
diets with 0.025 or 0.5% βG had decreased plasma haptoglobin and more pigs fed 
0.025% βG died by d12 after Streptococcus suis challenge than control pigs despite 
increased average daily food intake (Dritz et al. 1995).  Β-glucans at a dose of 0.03% did 
not enhance the immune response to vaccination with PRRS (Hiss and Sauerwein 2003).  
It is unclear which factors affected the outcomes of these studies. 
To date, minimal research has been done to explore the effects of βG on immune 
development of the lungs in very young animals or humans.  The research presented 
herein investigates the effects of dietary βG on the development of lung-associated 
adaptive immunity in individuals less than three weeks of age.  Immune characteristics 
analyzed include T cell phenotypes, cytokine secretion, and the antibody response to 
immunization with an intramuscular influenza vaccine. 
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Materials and Methods 
Chemicals 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless 
otherwise indicated.  
 
Dietary Yeast β-Glucan 
(1,3/1,6)-β-D-glucan (Wellmune WGP®) (see Appendix Figure B1) was obtained 
from Biothera, Inc. (Eagan, MN).  This compound was extracted from Saccharomyces 
cerevisiae.  The extraction process produces a whole glucan particle in which the outer 
surface of mannoprotein and inner cellular contents are removed (Babicek et al. 2007). 
WGP was provided at 1.8 mg/kg BW/day (WGP5), 18 mg/kg BW/day (WGP50) or 90 
mg/kg BW/day (WGP250).  The lowest dose provided an average WGP intake of 5 
mg/day and is consistent with Biothera's recommendation of 2 mg/kg BW/day.  The 
middle dose provided an average WGP intake of 50 mg/day. The highest dose provided 
an average WGP intake of 250 mg/d. These doses do not surpass the level generally 
recognized as safe by the United States FDA (200 mg/serving, GRN No. 239, 
www.FDA.gov accessed Oct 27, 2010).  Furthermore, these concentrations are within the 
range that has been shown to result in no observed adverse effects (NOAEL) in 
toxicological testing (2-100 mg/kg BW/day) (Babicek et al. 2007). 
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Dietary Treatment and Animal Protocol 
Piglets (n=68) were obtained at 48 h postpartum to allow for consumption of 
colostrum.  The piglets were randomized to one of four dietary treatment groups: 1) a 
medicated sow milk replacer formula (Formula; Milk Specialties Global Animal 
Nutrition, Carpentersville, IL); 2) Formula + 5 mg/L (WGP5); 3) Formula + 50 mg/L 
(WGP50); or 4) Formula + 250 mg/L (WGP250) (see Appendix Figure B2). Piglets were 
individually housed in environmentally controlled rooms (25°C) in cages, which maintain 
six piglets separated by Plexiglas partitions.  Radiant heaters were attached to the tops of 
the cages to maintain an ambient temperature of 30°C.  Formula was offered 14 times 
daily at a rate of 360 ml/kg BW/day.  The piglets were monitored daily for normal 
growth and food intake, as well as the presence of fever, diarrhea or lethargy.  All animal 
procedures were approved by the Institutional Animal Care and Use Committee of the 
University of Illinois. 
 
Vaccination 
On d7 postpartum, approximately half of the piglets in each treatment group 
(Formula n=5, WGP5 n=6, WGP50 n=5, WGP250 n=6) were vaccinated with a 0.25 ml 
i.m. injection of human influenza vaccine (Fluzone, Sanofi Pasteur, Swiftwater, PA) 
(see Appendix Figure B3).  A blood sample was drawn from the jugular vein prior to 
administration of the vaccine. Vaccinated animals were boosted on d14 with the same 
dose of Fluzone.  Blood samples were collected longitudinally from all piglets on d14 
and d21 by jugular vein or following euthanasia, respectively.  
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Sample Collection 
On day 7 (Formula n=5, WGP5 n=5, WGP50 n=5, WGP250 n=5) or day 21 
(Formula n=12, WGP5 n=13, WGP50 n=11, WGP250 n=12) post-partum, piglets were 
sedated with an intramuscular injection of Telazol (tiletamine HCl and zolazepam 
HCl,  3.5 mg/kg BW each, Pfizer Animal Health, Fort Dodge, IA).  After sedation, blood 
was collected by cardiac puncture into non-coated vacutainer tubes (BD Biosciences, 
Franklin Lakes, NJ) for serum isolation.  Piglets were then euthanized by an intravenous 
injection of sodium pentobarbital (Fatal Plus, Vortech Pharmaceuticals, Dearborn, 
Michigan; 72mg/kg body weight) and a thoracotomy was performed.  The lungs, 
mediastinal lymph nodes (MSLN) and thoracic lymph nodes (TLN) were quickly 
excised. Sections (3-4 cm) of the lung were snap frozen in liquid nitrogen or fixed in 
Bouin‟s solution. A portion of the MSLN and TLN were snap frozen in liquid nitrogen. 
The remaining MSLN and TLN were collected for isolation of mononuclear cells. 
 
Lung histomorphology and T cell Immunohistochemistry 
Bouin‟s-fixed lung samples were embedded in paraffin, sliced to approximately 
5μm with a microtome, and mounted on glass microscope slides.  Sections were then 
stained with hematoxylin and eosin or anti-human CD3 polyclonal antibody at the 
University of Illinois Veterinary Diagnostic Laboratory.  Slides were scanned in the 
Institute of Genomic Biology at the University of Illinois using the NanoZoomer Digital 
Pathology System (Hamamatsu Corporation, Bridgewater, NJ).  Images were then 
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analyzed by a board certified veterinary pathologist at the University of Illinois School of 
Veterinary Medicine. 
 
Isolation and Phenotypic Identification of Mononuclear Cells from Tissues 
Mononuclear cells from TLN and MSLN were obtained by cutting tissues into 
pieces and dissociating using a GentleMACS Dissociator (Miltenyi Biotec, Auburn, CA).  
Cells were then sequentially passed through 100um and 40um cell strainers (BD 
Biosciences, Bedford, MA) to form single cell suspensions.  Cells were counted using a 
Countess automated cell counter (Invitrogen, Carlsbad, CA).  The number of viable cells 
was assessed by trypan blue (Invitrogen Gibco) exclusion. The phenotypes of T 
lymphocyte subpopulations from MSLN and TLN were monitored by flow cytometry 
using a panel of fluorescently labeled mAbs.  Lymphocytes were identified by anti-swine 
CD45 (Clone K252-1E4, AbD Serotec, Raleigh, NC).  Anti-CD45 was conjugated to 
Alexa 647 with a Zenon Mouse Antibody Labeling Kit (Invitrogen Molecular Probes, 
Eugene, OR).  T lymphocytes were identified by mouse anti-pig CD3:biotin (Clone 
BB23-8E6, Southern Biotech, Birmingham, AL) which was visualized with 
streptavidin:PE-Cy7 (Southern Biotech). To further differentiate T cell populations, cells 
were stained with mouse anti-pig CD4:FITC (Clone 74-12-4, Southern Biotech) and 
mouse anti-pig CD8:PE (Clone 76-2-11, Southern Biotech). All staining procedures took 
place on ice and care was taken to prevent unnecessary exposure to light.  Briefly, one 
million cells per well were blocked with a mixture of 5% mouse serum (Southern 
Biotech) and 200ug/ml purified mouse IgG (Invitrogen) for 5min. Anti-CD3 was added 
to the wells, incubated for 20 min, centrifuged, and then fluid was aspirated. Cells were 
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then incubated for 20 min in a total volume of 40µl (10µl each: diluted Anti-CD45, 
Strep-PECy7, anti-CD4 and anti-CD8). Cells were washed twice with PBS/1% 
BSA/0.1% sodium azide, and then fixed with 2% paraformaldehyde. Staining was 
assessed using an LSRII flow cytometer (BD™, Biosciences, San Jose, CA). The relative 
number of T cell subpopulations was determined using FlowJo 7.0 software (FlowJo, 
Ashland, OR).  CD45+CD3+ events were considered T cells.  CD45+CD3+CD4+ events 
were considered T helper cells.  CD45+CD3+CD8+ event were considered cytotoxic T 
cells. Gating procedure is included in Appendix B, Figure B4. 
 
Mitogenic Cell Stimulation 
A total of 2 x 10
5 
cells/ml per well TLN and MSLN were plated in 96-well plates 
in a final volume of 200 μl complete culture medium (RPMI 1620 (Invitrogen Gibco), 
20% fetal calf serum (Invitrogen Gibco), 2 mM L-glutamine (Invitrogen Gibco), 50 
ug/ml gentamicin (Invitrogen Gibco), 100 μg/ml penicillin, and 100 μg/ml streptomycin) 
for 96 h at 37° C under 5% CO2.  20 μl of LPS (0.5% 20 ug/ml), 20 μl ConA (25 μg/ml), 
or 20 μl BSA 0.075 g per 1ml was added on d0 (n=3 wells per sample per stimulant).  
Plates were incubated for 72 hours, then pulsed with 
3
H-thymidine (1 µCi/ml; Perkin 
Elmer, Boston, MA) and incubated overnight.  Plates were stored at -80°C until analyzed.  
The cells were then harvested (TomTech, Harvester 96 Mach III M, Hamden, CT) onto 
1.5 µm glass fiber filter paper (Skatron Instruments, Sterling, VA) and placed into 
scintillation vials with either 7ml Ultima Gold™ F scintillation fluid (Perkin Elmer, 
Boston, MA) or Econo-Safe (Research Products International Corporation, Mt. Prospect, 
IL). Samples were counted on a Beckman Coulter, LS 6500 Scintillation System (Brea, 
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CA).  Data are expressed as a change in counts per minute (Δcpm) which was obtained 
by subtracting counts from unstimulated control wells from counts for wells with 
mitogens.  Samples were analyzed in triplicate.  Data analysis was done on log 
transformed CPM. 
 
Fluzone™ Preparation for Ex Vivo Analyses 
Prior to use in ex vivo assays, Fluzone™ was dialyzed to remove additives that 
inhibit cell proliferation.  The Fluzone™ solution was placed into Spectra/Por® 4 dialysis 
membranes (Spectrum Laboratories, Rancho Dominguez, CA) and submerged in PBS for 
24 hours at 4°C.  A Bradford Assay (Bio-Rad Quick Start Bradford, Bio-Rad, Hercules, 
CA) was done to compare pre-dialyzed and dialyzed Fluzone™ protein levels.  Both 
samples contained 130 μg protein/mL. 
 
Assessment of Cell-Mediated Response 
The cell-mediated immune (CMI) response of the piglets was monitored by 
stimulating TLN immune cells with dialyzed Fluzone™ ex vivo as had previously been 
used to assess CMI in response to the influenza vaccine in human subjects (Keylock et al. 
2007).  Cells (2 x 10
5
) were added to each well of a round bottom microtiter plates in 150 
μL of complete cell culture media (see above).  50 μL of Fluzone™ at concentrations of 5 
μg/ml, 2.5 μg/ml, 1.25 μg/ml, 0.625 μg/ml or 0 μg/ml was added to each well (n=3 wells 
per sample per stimulant).  On d4, 
3
H-thymidine (Perkin Elmer, Boston, MA) was added 
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at a concentration of 1 μCi per well and plates were incubated overnight. Plates of cells 
were treated and analyzed as they were for mitogenic stimulation above.   
 
Assessment of Antibody Response 
An enzyme-linked immunosorbent assay (ELISA) was used to detect swine IgG 
specific for influenza antigens.  Flat-bottomed ELISA plates (Nunc, Rochester, NY) were 
coated with dialyzed Fluzone vaccine at a 1:80 dilution in coating buffer [0.5M 
Carb/Bicarb Buffer, pH 9.6] and incubated overnight at 4°C. Following incubation, 
200µL of PBS/10% FBS was added to each well to block non-specific binding. 
Following incubation (1 hour at 4°C), the plate was washed three times with 
PBS/0.05%Tween 20.  50 µL of diluted sera (1:100 PBS/10% FBS) was added to each 
well and plates were incubated for 1 hour at 37°C. Plates were washed three times with 
PBS/Tween.  50 µL of goat anti-pig IgG conjugated to peroxidase was added to each well 
at a dilution of 1:400 in PBS/10%FBS. Following a1 hour incubation at 37°C, the plate 
was washed three times with PBS/0.05%Tween.  50 µL of TMB (BD Biosciences, San 
Diego, CA) was added.  The plate was allowed to develop at room temperature for 20 
min and the enzymatic reactions were stopped by addition of 1M sulfuric acid. The plate 
was then analyzed on a microplate spectrophotometer (SpectraMax M2e, Molecular 
Devices, Sunnyvale, CA) at 450 nm.  Samples were run in duplicate.  Positive stock 
serum was run on each plate in dilutions ranging from 1:100-1:1600.  A standard curve 
was made using these dilutions.  Fluzone-specific IgG was expressed in arbitrary units 
calculated from the linear portion of the standard curve. 
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Cytokine Expression 
Total RNA was isolated and purified from snap frozen lung, TLN, and MSLN 
samples with TRIzol reagent (Invitrogen).  RNA was quantified by spectrophotometry 
using a Nanodrop 1000 (Thermo Scientific, Rockford, IL) at 260 nm.  RNA 
concentration was adjusted to 0.25 µg/l using RNase free water (Invitrogen).  RNA 
quality was analyzed by a bioanalyzer (2100 Bioanalyzer, Agilent Technologies, Inc., 
Santa Clara, CA).  All samples had an RNA integrity number (RIN) greater than 6.0.  
Reverse transcription (RT) was performed on 3 μg of total RNA in a reaction involving 
100 mM deoxyribonucleotide triphosphate (dNTP), 10X RT Buffer, 10X RT Random 
Primers, MultiScribe Reverse Transciptase, RNAse inhibitor (High Capacity cDNA 
Reverse Transcription Kit, Applied Biosystems, Foster City, CA), and DEPC water 
(Invitrogen). The final RT product was quantified by spectrophotometry as above.  The 
final RT product was adjusted to a concentration of 1:150 or 1:200 using RNase free 
water. Quantitative real-time PCR was conducted using SYBR-Green (Roche Diagnostics 
GmbH, Mannheim, Germany) and fluorescence intensity was collected using the Taqman 
ABI 7900 machine (Applied Biosystems Inc., Foster City, CA). A total of 40 PCR cycles 
were run.  The primers used are listed in Table 4.1 and final primer concentrations were 
300 nM. Beta-actin was used as an internal standard reporter gene.  Results are expressed 
using the Relative Standard Curve Method.   In short, a dilution of standard curve from a 
stock of pooled porcine spleen cDNA was made and run on each plate. Each sample was 
run with primers to assess the target gene and beta-actin. Normalized values for each 
target were calculated by dividing the target quantity mean by the β-actin quantity mean.  
A fold difference was calculated for each measurement by dividing the normalized target 
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values by the normalized calibrator sample (in this case the day 21, control diet, non-
vaccinated group average). All samples that were statistically compared to each other 
were run on the same plate. 
 
Serum Immunoglobulin Levels 
Total serum immunoglobulin levels were detected by ELISA using assays specific 
for porcine IgG, IgM and IgA Quantification Sets (Bethyl Laboratories, Montgomery, 
TX, USA).  A 96-well, flat-bottomed ELISA plate (Nunc, Rochester, NY) was coated 
with 100 µl coating antibody (µg coating antibody as suggested by the manufacturer 
diluted in 0.05M carbonate-bicarbonate buffer, pH 9.6) and incubated overnight at 4°C. 
The antibody solution was poured off, and the plate was washed three times with 
PBS/0.05% Tween20.  The plates were blocked with 300 µl of 3% BSA/PBS for 1 h at 
room temperature (RT). The plates were washed as before. Serum samples were serially 
diluted in 0.05% gelatin/PBS, added to the wells in duplicate (100 µl per well), and plates 
were incubated for 1 h at RT. Samples for standard curves were included with the 
quantification sets and were used as directed.  Plates were washed as before, and 100 µl 
HRP-conjugated detection antibody (concentration as recommended by the manufacturer) 
in 0.05% gelatin/PBS was added to each well.  Plates were protected from light and 
incubated for 1 h at RT.  Plates were washed four times with PBS-Tween 20. 100 µl 
TMB reagent solution (OptEIA, BD Biosciences, San Diego, CA) was added to each well 
and allowed to develop protected from light at RT for the time recommended by the 
manufacturer.  The reaction was stopped with 100 µl 2N H2SO4 per well.  The 
absorbance was then read at 450 nm with 570 nm correction using a microplate reader 
77 
 
(SpectraMax M2
e
, Molecular Devices, Sunnyvale, CA). Total immunoglobulin values 
were determined based on a standard curve that was run on each plate. 
 
Statistical Analysis 
Analyses were performed using the PROC GLM (generalized linear model) 
procedure within SAS (Version 9.2, SAS Institute, Cary, NC).  The initial model was 
day, diet, vaccination, day x diet, vaccination x diet.  If the model was not significant 
vaccination was not significant, vaccinated and non-vaccinated were combined.  If the 
model was still not significant, d7 and d21 data were combined.  It diet was not 
significant, diet was excluded and all diet groups at d7 were combined and all diet groups 
at d21 were combined.  Statistical significance was defined as p<0.05, with trends 
reported as p<0.10.  All data are expressed as means ± SD.  
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Results 
Formula intake, Body Weight 
 Formula intake and body weight (see Appendix Figure B5) were measured daily 
to determine if WGP affected acceptance of diet or growth.  Formula intake and body 
weight were similar across all treatment groups. The piglets in all treatment groups ate 
most of the diet provided (95-99%).  An average formula intake of 808±167 ml/day was 
consumed for the first 7 days and 1488 ± 129 ml/day over the course of 21 days.  The 
increase in body weight during the 7 or 21 day period did not differ between groups. On 
day 7, each pig weighed an average of 2.3±0.5 kg.  On day 21, each pig weighed an 
average of 4.4±0.8 kg at day 21.  Therefore, inclusion of WGP had no effect on weight 
gain or dietary acceptance. 
 
T lymphocyte Populations  
 Flow cytometry was used to analyze T cell phenotype.  Neither WGP nor 
vaccination affected T cell phenotypes.  However,  MSLN and TLN CD45+CD3+CD4+ 
T cells decreased, while CD45+CD3+CD8+ T cells increased between d7 and d21 
(p<0.05) (Figure 4.1).  Double positive (CD4+CD8+) T cells did not show the expected 
increase from day 7 to day 21 in either the MSLN or the TLN (see Appendix Figure 
B6).  In MSLN, 7.1%±0.03 of CD45+CD3+ T Cells were double positive on d7 while 
8.3%±0.03 of CD45+CD3+ T Cells were double positive on day 21 (p=0.31).  In TLN, 
7.2%±0.02 of CD45+CD3+ T Cells were double positive on d7 while 9.1%±0.04 of 
CD45+CD3+ T Cells were double positive on day 21 in TLN (p=0.24).  Therefore, 
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neither vaccination nor dietary WGP affected the expected temporal changes in the 
transition from the overwhelming CD4+ helper cell predominance to an increased CD8+ 
cytotoxic T cell presence as the animals aged.  Although the expected increase in double-
positive T cells was not observed, this seemed to be independent of dietary or 
immunization treatment, and thus an artifact of our experimental system. 
 
Assessment of Antibody Response 
 To determine if fluzone-specific IgG was up-regulated in response to dietary βG 
treatment, a fluzone-specific ELISA was developed and serum IgG concentrations were 
evaluated (see Appendix Figure B7).  Vaccinated piglets had a significantly higher 
(p<0.0001) IgG titer at d14 and d21 than non-vaccinated animals (p<0.0001). Day 21 
piglets had a greater vaccine response compared to day 14 piglets (p<0.0001). Vaccinated 
piglets had a 5.9-fold increase in serum IgG of 5.9 ± 2.2 from d7 to d21, while non-
vaccinated piglets had increase (0.49-fold) in serum IgG from d7 to d21.  While 
vaccination increased fluzone-specific serum IgG production, dietary WGP did not 
enhance the ability of piglets to produce fluzone-specific IgG. 
 
Cytokines 
 Despite an absence of dietary effects on serum IgG production, we investigated 
mRNA expression of various genes in whole tissue samples from the lung, TLN, and 
MSLN.  Day, diet, and vaccination did not affect lung dectin, IL-1α, IL-2, IL-4, IL-12, or 
TNF-α mRNA expression (See Appendix Table B1).  However, day and diet affected 
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lung TGF-β1 and TGF-β2, respectively (Figure 4.2). Although lung TGF-β1 expression 
was unaffected by WGP or vaccination, lung TGFβ-1 mRNA expression increased 
between d7 and d21 (p<0.05).  WGP affected lung TGFβ-2 mRNA expression.  On both 
d7 and d21, lung TGFβ-2 mRNA expression was lower in all animals fed WGP 
compared to those fed formula alone (p<0.01).  IL-6 mRNA expression was not 
evaluated in the lung.  Day, diet nor vaccination affected TLN IL-4, IL-6, IL-12, TGFβ-1, 
TGFβ-2 or TNF-α mRNA expression (See Appendix Table B2).  Dectin mRNA 
expression was lower in TLN at d21 compared to d7 (p<0.05) (Figure 4.3).  IL-2 and IL-
1α were not analyzed in TLN because their expression was low in TLN.  Neither WGP, 
vaccination. nor day affected MSLN mRNA expression of dectin, IL-2, IL-4, IL-6, IL-12, 
TFGβ-1 or TNF-α (See Appendix Table B3).  MSLN TGFβ-2 mRNA expression 
increased from d7 to d21 (p<0.05) (Figure 4.4).  IL-1α mRNA expression could not be 
evaluated in MSLN because expression was below the detection limits of our assay.  The 
only effect of dietary treatment with WGP was decreased TGF-β2 expression in whole 
lung tissue. No consistent effects of vaccination or dietary WGP treatment could be seen 
on tissue-wide expression of inflammatory (IL-2, IL-12, IL-6, IL-1α, TNF-α) or anti-
inflammatory (IL-4, TGF-β1, TGF-β2) cytokine mRNA. 
 
Mitogenic Cell Stimulation and Cell-mediated response 
 To determine whether cell proliferation was increased by dietary WGP or 
vaccination, cells were stimulated with Fluzone™, LPS, BSA, or ConA.   In both MSLN 
and TLN, cells stimulated with ConA proliferated significantly (p<0.05) more than those 
treated with LPS, or BSA. The average log ∆CPM was 3.4 ± 1.7 in MSLN ConA 
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stimulated cells, 1.9 ± 1.4 in MSLN LPS treated cells, and 1.3 ± 1.3 in MSLN BSA 
treated cells. The average log ∆CPM was 4.2 ± 0.85 in TLN ConA stimulated cells, 2.0 ± 
1.2 in MSLN LPS treated cells, and 1.3 ± 1.1 in MSLN BSA treated cells (see Appendix 
Table B4).  Dietary WGP did not enhance proliferation of MSLN or TLN cells.  Even in 
vaccinated animals, TLN cells treated with different concentrations (0.625, 1.25, 2.5, and 
5 μg/mL) of dialyzed Fluzone™ did not proliferate more than untreated cells (see 
Appendix Table B5).  Neither diet nor vaccination significantly affected ex vivo cellular 
proliferation. 
 
Histomorphology and Immunohistochemistry 
 In order to evaluate the effects of WGP and vaccination on morphology, lung 
sections were excised, embedded in paraffin, sliced, mounted on slides, and stained with 
H&E (see Appendix Figure B8) or anti-human CD3 polyclonal antibody (see Appendix 
Figure B9).  Slides were analyzed by a board certified veterinary pathologist at the 
University of Illinois School of Veterinary Medicine who determined that there was no 
effect of WGP®, vaccination or day on CD3+ T-lymphocytes numbers or lung 
morphology. 
 
Serum Immunoglobulin Levels 
In order to determine if circulating immunoglobulin concentrations differed 
between formula and WGP250, sera from each both groups were analyzed for IgG, IgM, 
and IgA concentrations at d7, d14 and d21.  The serum IgG concentrations were higher 
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(p<0.05) at d7 than at d14 and d21 (Figure 4.5).  Serum IgG concentrations were 
unaffected by diet and vaccination.  The complete statistical model for serum IgM 
concentrations was not significant; therefore vaccinated animals were combined with 
non-vaccinated animals.  Formula piglets had higher (p=0.04) concentrations compared 
to WGP250 piglets (Figure 4.6).  IgM concentrations were unaffected by vaccination and 
day.  Serum IgA concentrations were higher (p<0.05) at d7 than at d14 and d21 (Figure 
4.7).  Serum IgA concentrations were unaffected by vaccination and diet. 
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Discussion 
 Β-glucans are polysaccharides that occur as a principal component of cellular 
walls.  βG have been shown to affect a variety of biological responses including 
activation of neutrophils (Zhang and Petty 1994), macrophages (Adachi et al. 1994; 
Lebron et al. 2003) complement (Saito et al. 1992) and possibly eosinophils 
(Mahauthaman et al. 1988).  In addition, βG have been shown to exhibit 
hypocholesterolemic (Shin et al. 2005; Zekovic et al. 2005; Bernardshaw et al. 2006), 
anticoagulant properties (Shin et al. 2005), and anti-tumorigenic effects in vivo (Chihara 
et al. 1969; Di Luzio et al. 1979). This study utilized a neonatal piglet model to further 
explore the effects of dietary WGP on lung immunity.  Overall, lung immune 
development in neonatal piglets was minimally affected by treatment with dietary WGP 
at 5, 50 or 250 mg/day.  Additionally, WGP was found to have no negative impacts on 
growth, dietary acceptance or the immune characterisitcs analyzed.   
One primary difference between the pig and the human involves the transfer of 
passive immunity.  The pig is born with virtually no circulating immunoglobulins due to 
the lack of placental transfer (Gaskins and Kelley 1995). Pigs, therefore, depend on 
colostrum and milk consumption for immunoglobulin immunity (Bourne 1976). βG 
added to milk may contribute to the immune development of piglets.  Cytokines are one 
immune factor that help protect neonates from pathogens.  The cytokine TGF-β1 is of 
particular interest because of the immunoregulatory role it plays during pregnancy and 
birth in humans as well as its role in the Th2 bias of neonatal immune responses (Laouar 
et al. 2005).  In vitro piglet studies have demonstrated that high concentrations (10 ng/ml- 
about the amount in piglet serum in the early suckling period) of TGF-β1 suppress the B 
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cell responses, while lower concentrations (0.1 ng/ml) of TGF-β1 increased the number 
of IgM and IgA short chain in response to both LPS and rotavirus antigens (Nguyen et al. 
2007).  Similarly murine TGF-β1 (0.1-10 ng/ml) acts in both early and late phases of IgA 
production, yet it suppresses IL-5 induced IgA synthesis in culture (Chen and Qing 
1990).  TGF-β1 has also been shown to down-regulate immune activation of intestinal 
epithelial cells and lamina propria immune cells (Mennechet et al. 2004) which is likely 
to allow for initial colonization of the intestine (Nguyen et al. 2007).  It has also been 
shown that TGF-β helps regulate innate IFN-γ which is a signal that controls TH1 
development (Laouar et al. 2005).  Laouar and collegues (2005) also showed that with 
blockage of TGF-β signaling in NK cells, which are the main source of innate IFN-γ 
production, NK cells increased and, therefore, the production of innate IFN-γ also 
increased which is responsible for TH1 differentiation.  In this study, TGF-β1 mRNA 
expression in the lung increased between d7 and d21 (p<0.05).  This is interesting 
because an increase in TGF-β1 is likely contributing to a shift from a TH1 response to a 
TH2 response counter to the expected TH2 to TH1 shift. 
The pig immune system is unique from humans and some other species in that 
blood and lymphoid tissues express double positive CD4+CD8+ subpopulations.  These 
subpopulations have been shown to increase with age and immunological experience 
(Zuckermann and Gaskins 1996).  Even though there was a trend for the population of 
double positive T cells to increase in both the MSLN and TLN, this increase did not 
reach significance.   However, the size of this population in our animals was in line with 
that published by others (between 8 and 64% of the circulating pool of T cells) 
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((Pescovitz et al. 1985; Pescovitz et al. 1994; Zuckermann and Husmann 1996; 
Zuckermann and Husmann 1996; Zuckermann 1999). 
Similar to our results, previous studies have shown a higher percentage of CD4+ 
than CD8+ cells in PBMCs of piglets (CD4/CD8 ratio >1) until the 40th day of life 
(Borghetti et al. 2006).  Borghetti et al. (2006) also observed that CD4+ cells decrease 
after about one week and eventually become lower than CD8+ cells.  We observed a 
similar shift in T cell populations in the MSLN and TLN (Figure 4.1).  Typical 
developmental changes in T lymphocyte populations were not enhanced by βG in this 
study.   
Furthermore, we found that βG at varying doses did not enhance the immune 
response to vaccination with Fluzone in our 21 day old piglets.  Vaccinated piglets had a 
higher amount of Fluzone-specific IgG at d14 and d21 than the non-vaccinated animals, 
which is to be expected, but contrary to our hypothesis, βG did not increase IgG 
production.  Influenza vaccines have been known to produce a protective effect which is 
largely dependent on the vaccine's ability to stimulate circulating antibody to the 
hemagglutinin (HA) (Hobson et al. 1972).  It is possible that the βG did not substantially 
interact with the vaccine to increase stimulation of the antibody since WGP was fed 
orally and the vaccine was administered intramuscularly.  Previous studies examining the 
effect of dietary supplementation with βG on the response to systemic immunization have 
produced mixed results.  In one study, piglets vaccinated with atrophic rhinitis vaccine 
produced significantly less antibody  when fed βG (Hahn et al. 2006) while, in another 
study, pigs injected with ovalbumin and receiving βG at a dose of 0.005% mounted a 
higher antibody response (Li et al. 2005).   
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Previous studies have questioned the ability of βG to target sensitive immune 
cells through the oral route (Gallois et al. 2009).  After absorption of the βG particles and 
uptake by the Peyer‟s Patches, the βG may remain in the GALT thus limiting exposure of 
other tissues to the βG, specifically lung tissue to the βG.  
Toll Like Receptors (TLRs) and other innate receptors were not examined in this 
study.  However, dectin-1 expression was measured.  In part, dectin was chosen because 
the mechanism by which this beta-glucan receptor translates recognition into intracellular 
signaling, stimulates cellular responses, and participates in coordinating the adaptive 
immune response is well-characterized (Goodridge et al. 2009).   It has been identified as 
one of the PRRs for β-glucan.  It is expressed mainly on phagocytes, especially 
macrophages and dendritic cells.  (Brown and Gordon 2001) suggest that dectin-1 signals 
alone are sufficient to trigger phagocytosis and (Dillon et al. 2006) suggests that when 
dectin-1 collaborates with TLR signaling cytokine production is regulated.  The decrease 
in dectin-1 in TLN from d7 to d21, seen in this study, may be a developmental effect 
which may impact the amount of phagocytosis and regulate cytokine production in the 
TLN. 
Evidence suggests that biological activity of βG are associated with their structure 
which, in turn, is dependent on the source and method of extraction and isolation.  
Processing (Bohn and BeMiller 1995; Douwes 2005; Mantovani et al. 2008), solubility, 
degree of polymerization (solubility increases as degree of polymerization increases) 
(Douwes 2005; Mantovani et al. 2008), high molecular weight (100-200 kDa) fractions 
being most active while fractions from the same source with lower molecular weights 
showed no activity (Fabre et al. 1984; Kojima et al. 1986; Blaschek et al. 1992), charge 
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of polymers and structure in aqueous media, and primary structure also contribute to 
functionality of βG.  Several previous studies used Hunter and co-workers‟. (Hunter et al. 
2002) method of extraction with some modifications (Li et al. 2005) with positive 
biological results.   In this study the βG was extracted from Saccharromyces cerevisiae 
using a proprietary technology, which produced a whole glucan particle in which the 
outer surface of mannoprotein and inner cellular contents are removed to expose the β 
1,3/1,6 glucan, WGP.  Perhaps this additional processing decreased recognition of the 
particle and therefore altered the absorption of the molecule.  Also, this processing may 
have decreased the solubility of the particle leading to limited absorption or decreased 
distribution of the βG in the formula due to the tube feeding method that was utilized.   It 
is also possible that, since the βG was compartmentalized in the gut, the βG could not 
impact the vaccination response which was localized in the muscle and could not impact 
the development of lung immunity which was localized in the chest (Holmgren and 
Czerkinsky 2005). It is likely that these factors also contributed to the lack of differences 
seen in lung histomorphology or immunohistochemistry.   
To gain a perspective of systemic immune development of piglets in the formula 
and WGP250 were compared.  Total serum IgG, IgM and IgA concentrations were 
measured.  We found that the serum IgG concentrations were higher (p<0.05) at d7 than 
at d14 and d21.  Our developmental study showed similar results as did Bourne‟s work 
(Bourne 1973).  Serum IgM concentrations were higher (p<0.05) in formula piglets 
compared to WGP250 piglets.  The overall developmental pattern was similar, however 
WGP250 decreased IgM concentrations, likely due to differences in colostrum received.  
IgA serum concentrations were higher on d7 than on d14 and d21 (P<0.05).  Our 
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previous developmental study as well as Bourne‟s research suggests that this is a 
typically developmental pattern (Bourne 1973). 
In conclusion, the effects of βG on lung immunity in the healthy neonate are 
inconclusive.  While no negative effects of the dietary supplement were seen, further 
research, perhaps targeted to effects on innate immune mechanisms or acute microbial 
challenges are needed to increase our understanding of the ability of WGP to enhance the 
biological activity of the neonate‟s immune system. 
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Table 4.1: Primers Used for Quantitative Real Time-PCR. 
 
 
Gene Forward Primer (5‟ to 3‟) Reverse Primer (5‟ to 3‟) Gene Bank Accession ID 
β-actin CACGCCATCCTGCGTCTGGA AGCACCGTGTTGGCGTAGAG DQ845171.1 
Dectin CTCTCACAACCTCACCAGGAGAT CAGTAATGGGTCGCCAATAAGG FJ386384.1 
IL-2 TCAACTCCTGCCACAATGT CTTGAAGTAGGTGCACCGT EU139160.1 
IL-12 CGTGCCTCGGGCAATTATAA CAGGTGAGGTCGCTAGTTTGG NM_213993.1 
IL-4 CACAGCGAGAAAGAACTCGT GTCCGCTCAGGAGGCTCTTC NM214123.1 
IL-6 CTGGCAGAAAACAACCTGAACC TGATTCTCATCAAGCAGGTCTCC AB194100.1 
IL-1α GTGCTCAAAACGAAGACGAACC CATATTGCCATGCTTTTCCCAGAA X52731.1 
TNF-α AACCTCAGATAAGCCCGTCG ACCACCAGCTGGTTGTCTTT EU682384.1 
TGF-β1 CCTGCAAGACCATCGACATG GCCGAAGCTTGGACAGAATC AF461808.1 
TGF-β2 TGTGTGCTGAGCGCTTTTCT GAGCGTGCTGCAGGTAGACA L08375.1 
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Figure 4.1: CD4:CD8 T cell ratios decrease in MSLN and TLN as piglets age. Piglets were euthanized on d7 or d21.  MSLN and 
TLN were collected.  Cells were isolated and stained with a panel of fluorescently labeled mAbs including CD45, CD3, CD4, and 
CD8.  No diet or vaccination differences were detected therefore data from all day 7 or all day 21 animals were pooled.  Data are 
expressed as mean ± SD.  Different letter superscripts indicate significant differences at p≤0.05.  A) MSLN CD45+CD3+CD4+ T cells 
decreased while CD45+CD3+CD8+ T cells increased between d7 and d21 (data shown as CD4+CD8+ ratio as percentage of 
CD45+CD3+ lymphocytes).  B) TLN CD45+CD3+CD4+ T cells decreased while CD45+CD3+CD8+ T cells increased between d7 
and d21. 
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Figure 4.2: TGF-β mRNA expression in lung.  Piglets were fed formula, WGP5, WGP50 or WGP250 and euthanized on d7 or d21.  
Lung tissue sections were excised and snap frozen.  Lung mRNA was isolated, purified, and quantified using qRT-PCR.  Normalized 
values for each target gene were calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold difference was 
calculated for each measurement by dividing the normalized target values by the average normalized target value for non-vaccinated, 
21 day old piglets fed the control diet. All samples that were statistically compared to each other were run on the same plate.  Data are 
expressed as mean ± SD of the fold difference relative to day 21, formula-fed, non-vaccinated animals.  Different letter superscripts 
indicate significant differences at p≤0.05.A) TGF-β1 mRNA expression increased between d7 and d21. No diet or vaccination 
differences were detected therefore data from all day 7 or all day 21 animals were pooled.   B) TGF-β2 expression in lung decreased 
with increasing dietary WGP. There were no day or vaccination differences; therefore all days and all vaccinated and non-
vaccinated groups were combined. 
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Figure 4.3: Dectin mRNA expression in TLN was lower at d21 compared to d7. Piglets were euthanized on d7 or d21.  TLN were 
excised and snap frozen.  mRNA was isolated, purified, and quantified by qRT-PCR.  Normalized values for each target were 
calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold difference was calculated for each measurement 
by dividing the normalized target values by the average normalized target value for non-vaccinated, 21 day old piglets fed the control 
diet. No diet or vaccination differences were detected therefore data from all day 7 or all day 21 animals were pooled. 
All samples that were statistically compared to each other were run on the same plate.  Data are expressed as mean ± SD.  Different 
letter superscripts indicate significant difference at p≤0.05. 
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Figure 4.4: TGF-β2 mRNA expression in MSLN increased from day 7 to day 21 in all pigs. Piglets were euthanized on d7 or d21.  
TLN were excised and snap frozen. MSLN mRNA was isolated, purified, and quantified using qRT-PCR. Normalized values for each 
target were calculated by dividing the target quantity mean by the β-actin quantity mean.  A fold difference was calculated for each 
measurement by dividing the normalized target values by the average normalized target value for non-vaccinated, 21 day old piglets 
fed the control diet. All samples that were statistically compared to each other were run on the same plate. No diet or vaccination 
differences were detected therefore data from all day 7 or all day 21 animals were pooled.  All samples that were statistically 
compared to each other were run on the same plate.  Data are expressed as mean ± SD.  Different letter superscripts indicate 
significant difference at p≤0.05.  
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Figure 4.5: Serum IgG concentrations in formula and WGP250 piglets.  Sera were collected on day 7, 14, and 21. Data are 
expressed as mean ± SD. Data with different letters are significantly different (p<0.05).  Serum IgG concentrations were higher on 
day 7 than on day 14 and day 21. 
 
 
 
0
10
20
30
40
50
60
d7 d14 d21
To
ta
l I
gG
 (m
g/
m
l)
 
Control High B-Glucan
Model: p = 0.002 
Day: p = <0.0001 
Diet: p = 0.6 
Vac: p = 0.9 
a 
b 
b 
95 
 
Figure 4.6: Serum IgM concentrations in formula and WGP250 piglets.  Sera were collected on day 7, 14, and 21. Data are 
expressed as mean ± SD. Data with different letters are significantly different (p<0.05).  Complete model was not significant, 
therefore, vaccinated and non-vaccinated data were pooled.  Serum IgM concentrations were higher in formula piglets than 
WGP250 piglets. 
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Figure 4.7: Serum IgA concentrations in formula and WGP250 piglets.  Sera were collected on day 7, 14, and 21. Data are 
expressed as mean ± SD. Data with different letters are significantly different (p<0.05).  Serum IgA concentrations were higher at 
d7 than at d14 or d21. 
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Chapter 5 
Conclusions and Future Directions 
 These studies focused on understanding the effects of diet on the immune 
development of the lung, TLN, and MSLN in neonates.  Our first objective was to 
identify differences in the BALT of SR versus FF piglets.   It is important to identify 
differences in feeding modes to increase our understanding of how breastfeeding 
provides a protective effect for the neonates as compared to formula feeding.  The 
implications of this research can be far reaching, particularly when they are applied to 
improving the immune system in neonates and, thereby, decreasing the ability of 
pathogenic microorganisms to attack the host.  Overall, our results showed that immune 
development in lung, TLN, and MSLN of SR and FF piglets differ in T cell 
subpopulations and mRNA expression, as well as serum immunoglobulin levels. 
Future work could investigate various respiratory infection models in order to 
increase understanding of whether immunological differences in lung, TLN and MSLN 
affect the neonate‟s ability to protect against the respiratory infection and/or how the 
neonate recovers from the infection.  This would help identify which specific immune 
characteristics increase the neonate‟s ability to cope with infection and what if any deter 
it.   It would also be interesting to look into various lobes of the lung to compare immune 
expression in order to further understand the interaction between immune parameters 
throughout the lung.  It would be informative to carry out a longer study to see if the 
immune differences occurring in the early stages of life continue through the transition 
from formula to feed and beyond and if any benefits/impairments are recognized from the 
early immune developmental variances. 
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In the second study, our objective was to investigate the effect of yeast β-glucan 
supplemented to formula on the development of mucosal immunity in the lung and also 
investigate the immune response to immunization with an influenza vaccine.  Overall, the 
results showed that yeast β-glucan supplemented to formula did very little to alter the 
development of mucosal immunity in the lung.  Despite the lack of impact yeast β-glucan 
had on immunological development in the lung in this study, it would be interesting to 
study the effects of yeast βG supplementation in an infection model where the neonate 
was challenged.  This may enhance any immunological differences the yeast βG 
supplementation provides to the neonate.  It would also be interesting to trace the WGP 
through the immune system similar to the studies Beier and Gebert (1998) completed 
with yeast βG in order to better understand the uptake and processing of the WGP 
particle.  This work would help to further our understanding of the impact of yeast βG 
supplementation on immunological development of the neonate. 
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Appendix A 
 
Supplemental Information: SR versus FF Study 
 
The first point of contact for inhaled substances such as environmental pollutants, 
cigarette smoke, airborne allergens and microorganisms are the epithelial lining of the 
upper airways and lungs (Diamond et al. 2000).  The lungs and upper airways are 
mucosal surfaces that have two purposes. They protect the organism from invasion of 
foreign antigens and bacteria, while allowing for the exchange of materials with the 
environment.  Due to the high exposure of the lungs and upper airways to airborne 
pathogens, they are common sites for infection. Immune factors such as IgA are secreted 
in the lungs which helps protect against respiratory infections.  The goal of this research 
was to better understand the development of immune cells in the lungs in sow-reared pigs 
compared to those that are formula-fed.  In order to increase understanding of the 
development of immune cells in the lungs, MSLN, and TLN, T lymphocyte 
subpopulations were identified, cytokine mRNA expression was evaluated and total IgG, 
IgM, and IgA expression was analyzed.  
In this study, 11, colostrum fed piglets received formula medicated sow milk 
replacer formula beginning at 48 hours of life and 12 piglets received sow milk through 
the duration of the study (Figure A1).  On d7, approximately half of the piglets in each 
group were euthanized and blood and tissue samples were collected. On d21 the other 
half of the piglets were euthanized and blood and tissue samples were collected.   
This study investigated the effects of diet on the development of lung immune 
development.  Flow cytometry was used to identify T cell subpopulations.  CD4:CD8 T 
cell ratios calculated and were not significantly different in PBMC at d7 or d 21 (Figure 
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A2).  Relative abundance of mRNA expression in lung (Table A1), TLN (Table A2), 
and MSLN (Table A3) was also evaluated.  Although several age and diet effects were 
seen in mRNA expression Lung, TLN, and MSLN (see Chapter 3), no differences were 
identified in mRNA expression of IL-1β, dectin, IL-12, and TGFβ-2 in lung, TGFβ-1, 
TGFβ-2, IL-6, IFN-α, and IFN-β in TLN, and IL-1β, IL-12, IL-6,  TGFβ-1, and TNF-α in 
MSLN.  Total serum immunoglobulin ELISAs were analyzed to better appreciate the 
immune system.  Sera was collected on day 7, 14, and 21.  Serum IgM levels in SR 
compared to FF piglets did not differ at p<0.05 (Figure A3). 
In conclusion, there were several immunological developmental differences 
between sow-reared and formula fed neonatal piglets. 
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Figure A1: Experimental Design. Piglets (n=23) were assigned to one of two dietary treatment groups: sow-reared or formula-fed.  
Piglets assigned to formula group received colostrum for 48 hours prior to transition to formula.  
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Figure A2: CD4:CD8 T cell ratios are not significantly different in d7 or d21 PBMC.  
Piglets were euthanized on d7 or d21.  PBMC were collected.  Cells were isolated and 
stained with a panel of fluorescently labeled mAb including CD45, CD3, CD4, and CD8.  
Data are expressed as mean ± SD.  Statistical significance was set at a p-value of p≤0.05. 
A) PBMC CD4:CD8 T cell ratios were not significant at d7.  B) PBMC CD4:CD8 T cell 
ratios were not significant at d21. 
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Table A1: Relative abundance of mRNA expression in lung.  Data are expressed as 
mean ± SD of the fold difference relative to day 7, formula-fed piglets. Statistical 
significance was set at a p-value of p≤0.05. 
 
 
  d7  d21   P-values 
  FF SR FF SR  
IL-β 1.0±0.72 0.71±0.28 0.66±0.40 1.87±1.45 0.1191 
Dectin 1.0±0.45 1.39±0.53 1.65±0.40 1.36±0.47 0.7897 
IL-12 1.0±1.0 0.32±0.85 1.1±0.94 1.75±1.77 0.2266 
TGFβ-2 1.0±0.48 1.12±0.41 1.51±1.14 1.30±0.35 0.6035 
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Table A2: Relative abundance of mRNA expression in TLN.  Data are expressed as 
mean ± SD of the fold difference relative to day 7, formula-fed piglets.  Statistical 
significance was set at a p-value of p≤0.05. 
 
 
  d7  d21   P-values 
  FF SR FF SR  
TGFβ-1 1.0±0.58 0.66±0.13 0.60±0.44 0.65±0.27 0.3494 
TGFβ-2 1.0±1.0 0.22±0.11 0.21±0.20 0.29±0.15 0.0546 
IL-6 1.0±0.39 0.41±0.09 0.59±0.08 0.32±0.11 0.0997 
IFN-α 1.0±1.7 0.02±0.001 0.18±0.12 0.02±0.001 0.1891 
IFN-β 1.0±1.77 0.001±0.0002 0.16±0.20 0.02±0.02 0.468 
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Table A3: Relative abundance of mRNA expression in MSLN.  Data are expressed as 
mean ± SD of the fold difference relative to day 7, formula-fed piglets. Statistical 
significance was set at a p-value of p≤0.05. 
 
 
  d7  d21   P-values 
  FF SR FF SR  
IL-1β 1.0±0.63 0.29±0.17 0.92±0.61 0.82±0.49 0.1569 
TNF-α 1.0±0.39 0.37±0.06 0.94±0.34 1.09±0.98 0.2479 
IL-12 1.0±0.62 0.16±0.03 0.56±0.21 0.62±0.56 0.0595 
TGFβ-1 1.0±0.35 0.43±0.02 1.02±0.44 0.87±0.60 0.1539 
IL-6 1.0±0.37 0.51±0.24 1.03±0.47 1.02±0.76 0.348 
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Figure A3: Serum IgM levels in SR and FF piglets.  Sera collected on day 7, 14, and 
21. Data are expressed as mean ± SD.  Statistical significance was set at a p-value of 
p≤0.05. 
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Appendix B 
 
Supplemental Information: β-Glucan Study 
 
Influenza is a major cause of morbidity and mortality in children worldwide, 
accounting for about 36,000 American deaths every year (CDC 2010).  It is generally 
believed that breast-fed infants are less susceptible to respiratory infections compared to 
formula-fed infants; however, a large percentage of infants are fed formula at some point 
during their first year of life.  Several studies have looked at the effects of adding various 
bioactive components to formula to enhance formula and the immunological protection it 
provides (Carver et al. 1990; Uauy et al. 1990; Newburg et al. 2005; Boehm and Stahl 
2007).  The goal of this research was to investigate the effect of yeast β-Glucan 
supplemented to infant formula on the development of mucosal immunity in the lung and 
explore the immune response to immunization with an influenza vaccine.  To better 
understand the effects of yeast β-Glucan supplemented to infant formula, fluzone specific 
serum IgG was assessed, histomorphology and immunohistochemistry in lung was 
analyzed, mRNA expression in MSLN, TLN, and Lung was evaluated, T cell populations 
were investigated using flow cytommetry, and mitogenic and fluzone cell stimulated 
were performed.   
In this study, 68 2-day-old piglets were divided into 4 groups with each group 
receiving formula with a differing amount of WGP® 1/3-1/6 β-D-glucan (Figure B1) 
((1) a medicated sow milk replacer formula  (Formula; Milk Specialties Global Animal 
Nutrition, Carpentersville, IL);  2) Formula + 1.8 mg WGP/kg BW/day (WGP5); 3) 
Formula + 18 mg WGP/kg BW/day (WGP50); or 4) Formula + 90 mg WGP/kg BW/day 
(WGP250))  (Figure B2).  On d7 approximately one third of the piglets in each group 
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were euthanized and blood and tissue samples were collected.  Approximately half of the 
remaining piglets in each treatment group (Formula n=5, WGP5 n=6, WGP50 n=5, 
WGP250 n=6) were vaccinated with a 0.25ml i.m. injection of human influenza vaccine 
(Fluzone, Sanofi Pasteur, Swiftwater, PA) (Figure B3).  A blood sample was drawn 
from the jugular vein prior to administration of the vaccine. Vaccinated animals were 
boosted on d14 with the same dose of Fluzone.  Blood samples were collected 
longitudinally from all piglets on d14 and d21 by jugular vein or following euthanasia, 
respectively.   The piglets were monitored daily for normal growth and food intake, as 
well as the presence of fever, diarrhea or lethargy, no differences were found across 
treatments groups for growth or food intake (Figure B5).  Formula was offered 14 times 
daily at a rate of 360 ml/kg BW/day.   
This study investigated the effects of dietary βG on the development of lung-
associated adaptive immunity.  One of these immune parameters was relative abundance 
of mRNA expression in Lung (Table B1), TLN (Table B2), and MSLN (Table B3).  
Although some age and diet effects were seen in mRNA expression in Lung, TLN, and 
MSLN (see Chapter 4), no differences were identified in mRNA expression of dectin, IL-
1α, IL-2, IL-4, IL-12, TNF-α in lung, IL-6, IL-12, TGFβ-1, TGFβ-2, and TNF-α in TLN, 
and dectin, IL-2, IL-4, IL-6, IL-12, TGFβ-1, and TNF-α in MSLN.   
Expression of T cell subpopulations was another immune parameter that was 
analyzed in TLN and MSLN.  Expression of double positive CD45+CD3+CD4+CD8+ T 
cells as a percentage of CD3+ lymphocytes were not different in respect to age or diet 
group (Figure B6).  Figure B4 exhibits the flow cytommetry gating procedure that was 
used to identify CD4+, CD8+, CD4+CD8+, and CD4-CD8- subpopulations. First the 
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lymphocyte population was selected on the side scatter vs. forward scatter plot.  Stained 
CD45+ cells were selected after comparing an unstained sample to a stained sample.  The 
region of positive CD45+ cells was identified by the area in the unstained sample graph 
that had <0.1% of the unstained cells in it.  That region was then mimicked in the stained 
sample graph. Stained CD3+ cells were selected after comparing the stained and 
unstained populations in a similar fashion.  Then CD8+, CD4+, and CD4+CD8+ cells 
were identified by comparing stained set to unstained set.   
Influenza specific serum IgG (Figure B7) was also analyzed.  While vaccination 
did increase influenza-specific serum IgG production, dietary WGP did not enhance the 
ability of piglets to produce fluzone-specific IgG.  Vaccinated piglets had a significantly 
higher (p<0.0001) IgG titer at d14 and d21 than non-vaccinated animals (p<0.0001). Day 
21 piglets had a greater vaccine response compared to day 14 piglets (p<0.0001). 
Vaccinated piglets had a fold increase in serum IgG of 5.9 ± 2.2 from d7 to d21 while 
non-vaccinated piglets had a fold increase in serum IgG of 0.49 ± 0.05 from d7 to d21.   
Mitogenic (Table B4) and Fluzone™ cell stimulation (Table B5) were completed 
to determine if WGP and/or vaccination enhanced cell proliferation.  MSLN and TLN 
cells were stimulated with LPS, BSA, or ConA. It was found that neither WGP nor 
vaccination enhanced cell proliferation in MSLN or TLN.  Cells stimulated with ConA 
proliferated significantly (p<0.05) more than those treated with LPS, or BSA.   TLN cells 
were stimulated with either 5 µg/ml, 2.5 µg/ml, 1.25 µg/ml, 0.625 µg/ml, or 0 µg/ml of 
dialyzed Fluzone™.  It was found that neither WGP nor vaccination enhanced cell 
proliferation.  
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Lastly, histomorphology (Figure B8) and immunohistochemistry (Figure B9) in 
lung were two other immune parameters that were examined. Vaccination, age and 
dietary WGP seemed to have an impact on the histomorphology or 
immunohistochemistry of lung tissue in piglets.  In conclusion, WGP only minimally 
impacted the neonatal piglet immune response. 
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Figure B1:  Structure of WGP® 1/3-1/6 β-D-glucan.  The β-glucan particulate is 
extracted from S. cerevisiae using acid and alkaline extraction techniques that results in 
stripping the outer mannoprotein sheath and loss of the inner cellular lipids and proteins, 
leaving the β-glucan shell (Babicek et al., 2007).   
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Figure B2: Experimental Design. Piglets (n=68) were randomized to one of four dietary treatment groups: a medicated sow milk 
replacer formula (Formula, Milk Specialties Company, Carpentersville, IL); Formula + 5 mg/L WGP® 1/3-1/6 β-D-glucan (WGP5); 
Formula + 50 mg/L WGP® 1/3-1/6 β-D-glucan (WGP50); or Formula + 250 mg/L WGP® 1/3-1/6 β-D-glucan (WGP250). 
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Figure B3:  Vaccination and sampling design. Piglets were euthanized on day 7 or day 
21.  Blood samples were taken on day 7 prior to vaccination, in animals being vaccinated, 
and day 14 in all animals.  Half of the animals in each diet group were vaccinated on day 
7.  These animals were boosted, with same dose, on day 14. 
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Figure B4: Flow cytometry gating procedure.  The lymphocyte population was selected on the side scatter vs forward scatter plot.  
Stained CD45+ cells were selected after comparing stained lymphocyte population to unstained lymphocyte population.  Stained 
CD3+ cells were selected after comparing the stained and unstained populations.  Then CD8+, CD4+, and CD4+CD8+ cells were 
identified by comparing stained set to unstained set.  
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Figure B5: Piglet weight and formula intake.  Data are expressed as mean ± SD.  
Statistical significance was set at p≤0.05.  The increase in body weight during the 7 or 21 
day period did not differ between groups.  On day 7, each pig weighed an average of 
2.3±0.5 kg.  On day 21, each pig weighed an average of 4.4±0.8 kg at day 21. Formula 
intake and body weight were similar across all treatment groups.  An average formula 
intake of 808±167 ml/day was consumed for the first 7 days and 1488±129 over the 
course of 21 days. Formula was offered 14 times daily at a rate of 360 ml/kg BW/day.    
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Figure B6: Expression of double positive CD45+CD3+CD4+CD8+ T cells as a percentage of CD3+ lymphocytes.  Data are 
expressed as mean ± SD.   Statistical significance was set at a p-value of p≤0.05.  A) MSLN CD45+CD3+CD4+CD8+ T cells B) TLN 
CD45+CD3+CD4+CD8+ T cells. 
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Figure B7: Influenza Specific Serum IgG.  IgG was measured by ELISA. Data are 
expressed as mean ± SD.  Statistical significance was set at p≤0.05.  Vaccinated piglets 
had a significantly higher (p<0.0001) IgG titer at d14 and d21 than non-vaccinated 
animals (p<0.0001). Day 21 piglets had a greater vaccine response compared to day 14 
piglets (p<0.0001). Vaccinated piglets had a fold increase in serum IgG of 5.9 ± 2.2 from 
d7 to d21 while non-vaccinated piglets had a fold increase in serum IgG of 0.49 ± 0.05 
from d7 to d21.  While vaccination did increase influenza-specific serum IgG production, 
dietary WGP did not enhance the ability of piglets to produce influenza-specific IgG. 
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Figure B8: Histomorphology: Haematoxylin and Eosin Stained Lung Images.  
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Figure B9: Immunohistochemistry, CD3+  Stained Lung Images. 
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Table B1: Relative abundance of mRNA expression in Lung.  Data are expressed as mean ± SD of the fold difference relative to 
day 21, formula-fed, non-vaccinated. Statistical significance was set at p≤0.05. 
 
 
 Day 7 Day 21 P-values 
 Formula WGP5 WGP50 WGP250 Formula WGP5 WGP50 WGP250 Model 
IL-1α 0.56±0.38 0.63±0.36 0.43±0.12 0.47±0.21 1.0±0.98 0.94±1.33 0.46±0.30 0.74±0.60 0.7502 
Dectin 0.97±0.61 0.71±0.35 0.71±0.35 0.69±0.15 1.0±0.75 0.62±0.52 0.89±0.14 0.85±0.41 0.6488 
IL-2 1.65±1.93 0.52±0.38 0.43±0.17 1.44±1.35 1.0±0.56 1.69±2.24 0.50±0.33 2.3±2.27 0.2178 
TNF-α 0.89±0.36 0.97±0.36 0.63±0.45 0.92±0.63 1.0±0.48 1.38±1.81 1.34±0.9 1.62±0.70 0.7021 
IL-4 0.85±0.40 0.70±0.38 0.40±0.07 0.53±0.17 1.0±1.0 0.91±0.87 0.81±0.78 0.93±0.70 0.7183 
IL-12 1.41±1.62 0.92±0.54 0.34±0.17 1.34±1.25 1.0±0.64 2.07±2.31 0.85±0.56 2.23±2.05 0.1761 
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Table B2: Relative abundance of mRNA expression in TLN.  Data are expressed as mean ± SD of the fold difference relative to 
day 21, formula-fed, non-vaccinated. Statistical significance was set at p≤0.05. 
 
 
 Day 7 Day 21 P-values 
 Formula WGP5 WGP50 WGP250 Formula WGP5 WGP50 WGP250 Model 
IL-6 1.43±0.55 1.21±0.28 0.72±0.25 1.73±0.88 1.0±0.31 1.18±0.81 1.64±0.79 0.90±0.48 0.0786 
IL-12 1.08±0.44 0.92±0.95 0.68±0.78 1.44±1.48 1.0±0.46 1.14±1.14 0.68±0.71 0.73±0.69 0.8443 
TGFβ-1 1.31±0.76 1.14±0.18 0.46±0.27 0.83±0.39 1.0±0.60 1.32±1.02 1.46±1.13 0.582±0.13 0.1055 
TGFβ-2 2.8±2.92 2.0±1.91 0.49±0.51 1.32±1.49 1.0±0.88 1.14±0.92 1.37±1.06 0.61±0.21 0.0739 
TNF-α 2.7±2.89 0.57±0.27 0.82±0.25 0.83±0.35 1.0±0.48 1.10±1.36 1.5±1.07 0.59±0.36 0.0775 
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Table B3: Relative abundance of mRNA expression in MSLN.   Data are expressed as mean ± SD of the fold difference relative to 
day 21, formula-fed, non-vaccinated. Statistical significance was set at p≤0.05. 
 
 
 Day 7 Day 21 P-values 
 Formula WGP5 WGP50 WGP250 Formula WGP5 WGP50 WGP250 Model 
Dectin 1.65±0.7 1.42±1.3 0.97±0.6 1.14±0.7 1.0±0.5 1.75±1.6 1.27±0.8 2.03±1.6 0.5942 
IL-12 2.83±1.8 0.97±1.3 0.26±0.1   0.32±0.3 1.0±0.8 1.03±2.2 1.03±2.2 0.15±0.07 0.0851 
TNF-α 1.24±0.3 0.96±0.6 0.75±0.5 0.70±0.3 1.0±0.4 0.85±0.5 0.91±0.5 1.57±1.3 0.3444 
IL-4 1.55±0.9 1.38±1.2 0.88±0.6 1.01±0.6 1.0±0.5 1.64±1.4 1.16±0.9 1.95±1.5 0.5738 
IL-6 1.39±0.6 0.84±0.3 0.78±0.7 0.71±0.4 1.0±0.5 0.97±0.4 1.06±0.4 1.19±0.9 0.539 
TGFβ-1 1.05±0.4 0.80±0.3 0.69±0.3 0.64±0.2 1.0±0.4 1.15±0.7 0.95±0.6 1.29±0.8 0.4093 
IL-2 2.49±1.5 0.86±0.5 1.09±1.0 1.21±1.2 1.0±0.4 1.41±1.0 1.12±0.5 1.87±0.6 0.0749 
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Table B4: Mitogenic Cell Stimulation (log ΔCPM) of TLN cells isolated from 21-day-old animals. Data are expressed as mean ± SD.  
Statistical significance was set at p≤0.05.  In both MSLN and TLN, cells stimulated with ConA proliferated significantly (p<0.05) 
more than those treated with LPS, or BSA.  Neither dietary WGP or vaccination enhanced proliferation were significant, therefore 
data from vaccinated and non-vaccinated animals and all diet groups were pooled.  Data within the same row with different letters are 
significantly different. 
 
 
 ConA LPS BSA 
MSLN 3.4±1.7
a 
1.9±1.4
b 
1.3±1.3
b 
TLN 4.2±0.85
a 
2.0±1.2
b 
1.3±1.1
b 
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Table B5: Fluzone Cell Stimulation (average non-log-transformed CPM) of TLN cells isolated from 21-day-old animals.  Data were 
expressed are mean ± SD.  Statistical significance was set at p≤0.05.  
 
 
 Non-vaccinated Vaccinated 
 Formula 
N=7 
WGP5 
N=7 
WGP50 
N=6 
WGP250 
N=6 
Formula 
N=5 
WGP5 
N=6 
WGP50 
N=5 
WGP250 
N=6 
Unstimulated  258.4±237.4 331.7±257.2 148.0±119.6 424.9±363.5 163.1±123.4 275.1±211.2 515.6±190.9 447.7±342.3 
5 μg/mL 
 
161.2±140.4 225.1±229.6 70.6±38.2 203.9±163.4 109.2±24.0 165.7±99.6 188.0±121.56 288.6±218.6 
2.5 μg/mL 
 
210.4±196.9 310.0±85.9 118.8±38.1 243.2±98.8 178.6±73.4 212.6±142.7 252.8±108.2 538.8±428.7 
1.25 μg/mL 
 
234.0±232.1 351.5±62.2 140.3±102.7 382.2±334.9 225.5±181.1 256.3±150.0 338±244.0 398.8±210.0 
0.625 μg/mL 
 
168.6±125.0 250.7±146.8 184.4±141.0 323.3±253.1 344.8±296.5 257.9±152.0 460.5±359.6 347.9±402.6 
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